Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-139-5p CDH1 -1.42 0 0.84 0.00809 PITA; miRanda -0.53 0 NA
2 hsa-miR-199a-5p CDH1 0.72 6.0E-5 0.84 0.00809 MirTarget; miRanda -0.38 0.00041 25080937 In contrast inhibition of miR-199a-5p impaired the metastatic potential of GC cells in vitro and in vivo and E-cadherin was identified as a direct and functional target of miR-199a-5p in GC cells
NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 136 1672 2.214e-63 1.03e-59
2 CELL DEVELOPMENT 117 1426 1.234e-53 2.871e-50
3 REGULATION OF CELL DIFFERENTIATION 118 1492 1.917e-52 2.973e-49
4 TISSUE DEVELOPMENT 118 1518 1.213e-51 1.411e-48
5 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 104 1142 2.641e-51 2.458e-48
6 BIOLOGICAL ADHESION 99 1032 1.13e-50 8.76e-48
7 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 110 1395 2.631e-48 1.749e-45
8 REGULATION OF CELLULAR COMPONENT MOVEMENT 84 771 8.397e-47 4.884e-44
9 CARDIOVASCULAR SYSTEM DEVELOPMENT 83 788 4.623e-45 2.151e-42
10 CIRCULATORY SYSTEM DEVELOPMENT 83 788 4.623e-45 2.151e-42
11 ORGAN MORPHOGENESIS 85 841 8.763e-45 3.707e-42
12 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 92 1021 1.738e-44 6.738e-42
13 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 89 957 4.774e-44 1.709e-41
14 RESPONSE TO ENDOGENOUS STIMULUS 106 1450 3.092e-43 1.028e-40
15 POSITIVE REGULATION OF CELL DIFFERENTIATION 82 823 1.237e-42 3.838e-40
16 VASCULATURE DEVELOPMENT 64 469 2.824e-41 8.213e-39
17 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 97 1275 1.129e-40 3.09e-38
18 NEUROGENESIS 101 1402 2.078e-40 5.372e-38
19 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 65 513 6.767e-40 1.657e-37
20 CELLULAR COMPONENT MORPHOGENESIS 82 900 1.077e-39 2.505e-37
21 REGULATION OF CELL PROLIFERATION 102 1496 1.005e-38 2.228e-36
22 LOCOMOTION 88 1114 7.221e-38 1.527e-35
23 TISSUE MORPHOGENESIS 63 533 8.164e-37 1.652e-34
24 BLOOD VESSEL MORPHOGENESIS 54 364 1.119e-36 2.17e-34
25 REGULATION OF CELL DEVELOPMENT 76 836 1.418e-36 2.639e-34
26 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 107 1848 2.209e-34 3.954e-32
27 POSITIVE REGULATION OF GENE EXPRESSION 102 1733 3.472e-33 5.983e-31
28 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 77 983 1.3e-32 2.16e-30
29 REGULATION OF NEURON DIFFERENTIATION 59 554 6.409e-32 1.028e-29
30 EXTRACELLULAR STRUCTURE ORGANIZATION 46 304 1.19e-31 1.846e-29
31 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 67 750 1.243e-31 1.866e-29
32 REGULATION OF CELL DEATH 92 1472 1.288e-31 1.873e-29
33 RESPONSE TO WOUNDING 59 563 1.555e-31 2.193e-29
34 CELL MOTILITY 70 835 2.343e-31 3.114e-29
35 LOCALIZATION OF CELL 70 835 2.343e-31 3.114e-29
36 POSITIVE REGULATION OF RESPONSE TO STIMULUS 105 1929 2.433e-31 3.144e-29
37 EPITHELIUM DEVELOPMENT 74 945 2.826e-31 3.554e-29
38 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 68 801 9.16e-31 1.122e-28
39 REGULATION OF CELL ADHESION 61 629 1.014e-30 1.21e-28
40 RESPONSE TO OXYGEN CONTAINING COMPOUND 87 1381 5.168e-30 6.011e-28
41 POSITIVE REGULATION OF CELL COMMUNICATION 91 1532 1.443e-29 1.638e-27
42 CELL PROJECTION ORGANIZATION 70 902 2.784e-29 3.084e-27
43 RESPONSE TO EXTERNAL STIMULUS 98 1821 1.263e-28 1.367e-26
44 NEURON DIFFERENTIATION 68 874 1.742e-28 1.842e-26
45 POSITIVE REGULATION OF LOCOMOTION 49 420 2.504e-28 2.59e-26
46 TUBE DEVELOPMENT 55 552 2.88e-28 2.913e-26
47 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 97 1805 2.971e-28 2.941e-26
48 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 77 1152 5.024e-28 4.675e-26
49 REGULATION OF CELL PROJECTION ORGANIZATION 55 558 4.972e-28 4.675e-26
50 RESPONSE TO ORGANIC CYCLIC COMPOUND 69 917 4.826e-28 4.675e-26
51 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 96 1784 5.61e-28 5.118e-26
52 ANGIOGENESIS 42 293 5.805e-28 5.195e-26
53 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 72 1008 6.748e-28 5.924e-26
54 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 92 1656 9.909e-28 8.538e-26
55 SINGLE ORGANISM CELL ADHESION 50 459 1.684e-27 1.425e-25
56 RESPONSE TO GROWTH FACTOR 50 475 8.306e-27 6.901e-25
57 SKELETAL SYSTEM DEVELOPMENT 49 455 9.978e-27 8.009e-25
58 NEURON PROJECTION DEVELOPMENT 53 545 9.983e-27 8.009e-25
59 REGULATION OF PROTEIN MODIFICATION PROCESS 92 1710 1.071e-26 8.446e-25
60 UROGENITAL SYSTEM DEVELOPMENT 41 299 1.543e-26 1.196e-24
61 RESPONSE TO LIPID 66 888 1.742e-26 1.329e-24
62 MORPHOGENESIS OF AN EPITHELIUM 46 400 2.424e-26 1.791e-24
63 RESPONSE TO HORMONE 66 893 2.399e-26 1.791e-24
64 WOUND HEALING 49 470 4.368e-26 3.175e-24
65 EMBRYONIC MORPHOGENESIS 52 539 4.634e-26 3.317e-24
66 REGULATION OF PHOSPHORUS METABOLIC PROCESS 88 1618 8.992e-26 6.34e-24
67 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 84 1492 1.568e-25 1.089e-23
68 NEGATIVE REGULATION OF CELL DEATH 64 872 2.3e-25 1.574e-23
69 NEURON PROJECTION MORPHOGENESIS 45 402 2.775e-25 1.871e-23
70 NEURON DEVELOPMENT 57 687 3.284e-25 2.183e-23
71 POSITIVE REGULATION OF CELL DEVELOPMENT 48 472 4.413e-25 2.892e-23
72 EMBRYO DEVELOPMENT 64 894 9.033e-25 5.838e-23
73 TAXIS 47 464 1.713e-24 1.092e-22
74 CELL CELL ADHESION 53 608 1.877e-24 1.18e-22
75 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 67 1004 3.189e-24 1.979e-22
76 TUBE MORPHOGENESIS 40 323 3.363e-24 2.059e-22
77 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 68 1036 3.494e-24 2.084e-22
78 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 68 1036 3.494e-24 2.084e-22
79 POSITIVE REGULATION OF NEURON DIFFERENTIATION 39 306 4.446e-24 2.619e-22
80 REGULATION OF NEURON PROJECTION DEVELOPMENT 44 408 4.566e-24 2.656e-22
81 REGULATION OF OSSIFICATION 31 178 1.816e-23 1.043e-21
82 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 77 1360 1.941e-23 1.101e-21
83 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 70 1135 2.42e-23 1.357e-21
84 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 38 303 3.171e-23 1.756e-21
85 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 41 368 5.228e-23 2.862e-21
86 CELL JUNCTION ORGANIZATION 31 185 6.087e-23 3.293e-21
87 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 44 437 7.444e-23 3.981e-21
88 REGULATION OF MAPK CASCADE 53 660 8.765e-23 4.634e-21
89 NEGATIVE REGULATION OF CELL DIFFERENTIATION 51 609 9.487e-23 4.96e-21
90 HEART DEVELOPMENT 45 466 1.29e-22 6.667e-21
91 NEGATIVE REGULATION OF LOCOMOTION 35 263 2.525e-22 1.277e-20
92 CENTRAL NERVOUS SYSTEM DEVELOPMENT 60 872 2.502e-22 1.277e-20
93 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 60 876 3.154e-22 1.578e-20
94 POSITIVE REGULATION OF MOLECULAR FUNCTION 87 1791 4.187e-22 2.073e-20
95 CELL PART MORPHOGENESIS 51 633 5.364e-22 2.627e-20
96 NEGATIVE REGULATION OF CELL PROLIFERATION 51 643 1.078e-21 5.225e-20
97 POSITIVE REGULATION OF CELL PROLIFERATION 57 814 1.413e-21 6.776e-20
98 CONNECTIVE TISSUE DEVELOPMENT 30 194 3.453e-21 1.639e-19
99 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 52 689 3.842e-21 1.806e-19
100 CELL SUBSTRATE ADHESION 28 164 4.729e-21 2.201e-19
101 MESENCHYME DEVELOPMENT 29 190 2.359e-20 1.087e-18
102 NEGATIVE REGULATION OF CELL COMMUNICATION 67 1192 3.923e-20 1.789e-18
103 CARTILAGE DEVELOPMENT 26 147 4.959e-20 2.24e-18
104 POSITIVE REGULATION OF MAPK CASCADE 42 470 7.115e-20 3.183e-18
105 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 54 799 9.504e-20 4.212e-18
106 MORPHOGENESIS OF A BRANCHING STRUCTURE 27 167 1.071e-19 4.702e-18
107 REGULATION OF CELL MORPHOGENESIS 45 552 1.158e-19 5.036e-18
108 REGULATION OF GROWTH 48 633 1.25e-19 5.386e-18
109 GROWTH 39 410 1.855e-19 7.919e-18
110 REGULATION OF IMMUNE SYSTEM PROCESS 72 1403 1.952e-19 8.258e-18
111 REGULATION OF EPITHELIAL CELL PROLIFERATION 33 285 3.362e-19 1.409e-17
112 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 51 740 4.956e-19 2.059e-17
113 POSITIVE REGULATION OF CELL ADHESION 37 376 5.362e-19 2.208e-17
114 RESPONSE TO STEROID HORMONE 42 497 5.698e-19 2.326e-17
115 DEVELOPMENTAL GROWTH 35 333 6.175e-19 2.498e-17
116 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 30 232 6.503e-19 2.609e-17
117 REGULATION OF VASCULATURE DEVELOPMENT 30 233 7.36e-19 2.927e-17
118 HEAD DEVELOPMENT 49 709 2.371e-18 9.349e-17
119 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 56 926 3.013e-18 1.178e-16
120 EPITHELIAL CELL DIFFERENTIATION 41 495 3.192e-18 1.238e-16
121 REGULATION OF OSTEOBLAST DIFFERENTIATION 22 112 3.704e-18 1.424e-16
122 POSITIVE REGULATION OF CATALYTIC ACTIVITY 73 1518 3.869e-18 1.476e-16
123 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 43 554 5.075e-18 1.92e-16
124 EMBRYONIC ORGAN DEVELOPMENT 37 406 6.959e-18 2.611e-16
125 REGULATION OF HYDROLASE ACTIVITY 67 1327 1.077e-17 4.008e-16
126 EMBRYONIC ORGAN MORPHOGENESIS 31 279 1.409e-17 5.203e-16
127 STEM CELL DIFFERENTIATION 26 190 3.726e-17 1.365e-15
128 CELL PROLIFERATION 46 672 4.219e-17 1.534e-15
129 KIDNEY EPITHELIUM DEVELOPMENT 22 125 4.406e-17 1.589e-15
130 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 28 229 4.482e-17 1.604e-15
131 MUSCLE STRUCTURE DEVELOPMENT 37 432 5.353e-17 1.901e-15
132 OSSIFICATION 29 251 5.677e-17 2.001e-15
133 REGULATION OF ENDOTHELIAL CELL MIGRATION 21 114 8.737e-17 3.057e-15
134 SENSORY ORGAN DEVELOPMENT 39 493 1.077e-16 3.738e-15
135 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 22 131 1.249e-16 4.303e-15
136 GLAND DEVELOPMENT 35 395 1.382e-16 4.729e-15
137 REGULATION OF EPITHELIAL CELL MIGRATION 24 166 1.749e-16 5.94e-15
138 SYSTEM PROCESS 77 1785 1.764e-16 5.948e-15
139 CELL MATRIX ADHESION 21 119 2.189e-16 7.326e-15
140 REGULATION OF CELL ACTIVATION 38 484 3.514e-16 1.168e-14
141 CELL ACTIVATION 41 568 4.103e-16 1.354e-14
142 RESPONSE TO ALCOHOL 33 362 4.675e-16 1.532e-14
143 REGULATION OF RESPONSE TO STRESS 68 1468 4.78e-16 1.555e-14
144 HEART MORPHOGENESIS 26 212 5.723e-16 1.849e-14
145 POSITIVE REGULATION OF CELL DEATH 42 605 6.879e-16 2.208e-14
146 PATTERN SPECIFICATION PROCESS 35 418 7.935e-16 2.529e-14
147 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 38 498 8.924e-16 2.825e-14
148 IMMUNE SYSTEM DEVELOPMENT 41 582 9.514e-16 2.991e-14
149 NEGATIVE REGULATION OF GENE EXPRESSION 68 1493 1.113e-15 3.476e-14
150 CELL JUNCTION ASSEMBLY 21 129 1.206e-15 3.74e-14
151 REGULATION OF CELLULAR LOCALIZATION 62 1277 1.429e-15 4.404e-14
152 SKELETAL SYSTEM MORPHOGENESIS 25 201 1.52e-15 4.653e-14
153 NEPHRON DEVELOPMENT 20 115 1.548e-15 4.709e-14
154 IMMUNE SYSTEM PROCESS 80 1984 1.766e-15 5.337e-14
155 DIGESTIVE SYSTEM DEVELOPMENT 22 148 1.801e-15 5.407e-14
156 REGULATION OF KINASE ACTIVITY 47 776 2.069e-15 6.17e-14
157 RESPONSE TO OXYGEN LEVELS 30 311 2.357e-15 6.984e-14
158 NEURON PROJECTION GUIDANCE 25 205 2.426e-15 7.145e-14
159 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 36 465 3.453e-15 1.01e-13
160 REGULATION OF TRANSPORT 75 1804 3.516e-15 1.023e-13
161 RESPONSE TO NITROGEN COMPOUND 49 859 5.04e-15 1.457e-13
162 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 16 67 5.61e-15 1.611e-13
163 REGULATION OF CELL CELL ADHESION 32 380 1.26e-14 3.597e-13
164 REGULATION OF ORGAN MORPHOGENESIS 26 242 1.435e-14 4.072e-13
165 FOREBRAIN DEVELOPMENT 31 357 1.449e-14 4.085e-13
166 RESPONSE TO ABIOTIC STIMULUS 53 1024 1.809e-14 5.069e-13
167 REGULATION OF ACTIN FILAMENT BASED PROCESS 29 312 1.854e-14 5.165e-13
168 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 30 337 2.038e-14 5.645e-13
169 REGULATION OF RESPONSE TO WOUNDING 33 413 2.143e-14 5.901e-13
170 REGULATION OF CELLULAR COMPONENT BIOGENESIS 45 767 2.753e-14 7.536e-13
171 REGULATION OF CELL GROWTH 32 391 2.797e-14 7.611e-13
172 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 66 1517 2.888e-14 7.812e-13
173 MESENCHYMAL CELL DIFFERENTIATION 20 134 3.269e-14 8.793e-13
174 POSITIVE REGULATION OF TRANSPORT 50 936 3.311e-14 8.855e-13
175 REGULATION OF HOMEOSTATIC PROCESS 34 447 3.558e-14 9.461e-13
176 POSITIVE REGULATION OF HYDROLASE ACTIVITY 49 905 3.72e-14 9.835e-13
177 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 18 103 3.794e-14 9.918e-13
178 REGULATION OF NEURON DEATH 26 252 3.78e-14 9.918e-13
179 REGULATION OF CARTILAGE DEVELOPMENT 15 63 4.227e-14 1.099e-12
180 REGULATION OF INTRACELLULAR TRANSPORT 40 621 4.275e-14 1.105e-12
181 MESONEPHROS DEVELOPMENT 17 90 5.119e-14 1.316e-12
182 REGULATION OF CYTOPLASMIC TRANSPORT 35 481 5.447e-14 1.393e-12
183 REGULATION OF ERK1 AND ERK2 CASCADE 25 238 7.899e-14 2.008e-12
184 AGING 26 264 1.138e-13 2.879e-12
185 REGULATION OF CHEMOTAXIS 22 180 1.15e-13 2.892e-12
186 POSITIVE REGULATION OF CELL ACTIVATION 28 311 1.185e-13 2.965e-12
187 REGULATION OF ION HOMEOSTASIS 23 201 1.302e-13 3.24e-12
188 HOMEOSTATIC PROCESS 60 1337 1.449e-13 3.585e-12
189 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 34 470 1.514e-13 3.727e-12
190 INTRACELLULAR SIGNAL TRANSDUCTION 66 1572 1.532e-13 3.751e-12
191 POSITIVE REGULATION OF OSSIFICATION 16 84 2.504e-13 6.099e-12
192 RESPONSE TO INORGANIC SUBSTANCE 34 479 2.603e-13 6.309e-12
193 ADHERENS JUNCTION ORGANIZATION 15 71 2.826e-13 6.812e-12
194 POSITIVE REGULATION OF KINASE ACTIVITY 34 482 3.11e-13 7.459e-12
195 NEGATIVE REGULATION OF NEURON DEATH 21 171 3.837e-13 9.156e-12
196 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 46 867 5.105e-13 1.212e-11
197 MUSCLE CELL DIFFERENTIATION 24 237 5.65e-13 1.334e-11
198 REGULATION OF HOMOTYPIC CELL CELL ADHESION 27 307 5.804e-13 1.364e-11
199 ARTERY DEVELOPMENT 15 75 6.654e-13 1.556e-11
200 RESPONSE TO ESTROGEN 23 218 7.358e-13 1.712e-11
201 ENDOTHELIUM DEVELOPMENT 16 90 7.726e-13 1.789e-11
202 ARTERY MORPHOGENESIS 13 51 8.31e-13 1.914e-11
203 REGULATION OF DEVELOPMENTAL GROWTH 26 289 9.405e-13 2.156e-11
204 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 20 162 1.278e-12 2.915e-11
205 NEPHRON EPITHELIUM DEVELOPMENT 16 93 1.313e-12 2.975e-11
206 RESPONSE TO KETONE 21 182 1.317e-12 2.975e-11
207 REGULATION OF MAP KINASE ACTIVITY 27 319 1.443e-12 3.244e-11
208 MUSCLE TISSUE DEVELOPMENT 25 275 2.076e-12 4.644e-11
209 REGULATION OF CALCIUM ION TRANSPORT 22 209 2.468e-12 5.494e-11
210 GLAND MORPHOGENESIS 16 97 2.584e-12 5.725e-11
211 PROTEIN PHOSPHORYLATION 47 944 2.656e-12 5.856e-11
212 NEGATIVE REGULATION OF CELL DEVELOPMENT 26 303 2.788e-12 6.119e-11
213 REGULATION OF TRANSFERASE ACTIVITY 47 946 2.861e-12 6.249e-11
214 REGULATION OF PROTEIN LOCALIZATION 47 950 3.317e-12 7.212e-11
215 LEUKOCYTE MIGRATION 24 259 3.868e-12 8.37e-11
216 REGULATION OF WNT SIGNALING PATHWAY 26 310 4.69e-12 1.01e-10
217 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 19 154 4.777e-12 1.024e-10
218 IN UTERO EMBRYONIC DEVELOPMENT 26 311 5.046e-12 1.072e-10
219 REGIONALIZATION 26 311 5.046e-12 1.072e-10
220 REGULATION OF BODY FLUID LEVELS 33 506 6.042e-12 1.278e-10
221 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 21 197 6.171e-12 1.299e-10
222 VASCULOGENESIS 13 59 6.306e-12 1.322e-10
223 ACTIN FILAMENT BASED PROCESS 31 450 6.791e-12 1.411e-10
224 POSITIVE REGULATION OF CHEMOTAXIS 17 120 6.788e-12 1.411e-10
225 LYMPHOCYTE ACTIVATION 27 342 7.381e-12 1.526e-10
226 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 17 121 7.787e-12 1.603e-10
227 CARDIAC CHAMBER MORPHOGENESIS 16 104 7.827e-12 1.604e-10
228 DIVALENT INORGANIC CATION HOMEOSTASIS 27 343 7.899e-12 1.612e-10
229 RESPONSE TO ACID CHEMICAL 26 319 8.964e-12 1.821e-10
230 BEHAVIOR 33 516 1.023e-11 2.069e-10
231 REGULATION OF SEQUESTERING OF CALCIUM ION 16 107 1.225e-11 2.468e-10
232 CELL FATE COMMITMENT 22 227 1.292e-11 2.58e-10
233 EXTRACELLULAR MATRIX DISASSEMBLY 14 76 1.292e-11 2.58e-10
234 CELLULAR RESPONSE TO HORMONE STIMULUS 34 552 1.364e-11 2.702e-10
235 REGULATION OF METAL ION TRANSPORT 26 325 1.363e-11 2.702e-10
236 CARDIAC CHAMBER DEVELOPMENT 18 144 1.409e-11 2.777e-10
237 REPRODUCTIVE SYSTEM DEVELOPMENT 29 408 1.578e-11 3.099e-10
238 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 21 207 1.6e-11 3.128e-10
239 MUSCLE ORGAN DEVELOPMENT 24 277 1.617e-11 3.148e-10
240 EPITHELIAL CELL DEVELOPMENT 20 186 1.695e-11 3.287e-10
241 RESPONSE TO MECHANICAL STIMULUS 21 210 2.106e-11 4.067e-10
242 REGULATION OF AXONOGENESIS 19 168 2.26e-11 4.345e-10
243 REGULATION OF NEURON APOPTOTIC PROCESS 20 192 3.039e-11 5.82e-10
244 CELL CELL SIGNALING 40 767 3.34e-11 6.368e-10
245 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 19 172 3.425e-11 6.504e-10
246 CIRCULATORY SYSTEM PROCESS 27 366 3.519e-11 6.656e-10
247 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 17 133 3.661e-11 6.894e-10
248 ANTERIOR POSTERIOR PATTERN SPECIFICATION 20 194 3.674e-11 6.894e-10
249 STRIATED MUSCLE CELL DIFFERENTIATION 19 173 3.793e-11 7.064e-10
250 INTEGRIN MEDIATED SIGNALING PATHWAY 14 82 3.795e-11 7.064e-10
251 GLIOGENESIS 19 175 4.642e-11 8.606e-10
252 CELLULAR RESPONSE TO LIPID 30 457 4.98e-11 9.195e-10
253 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 18 156 5.481e-11 1.008e-09
254 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 24 296 6.49e-11 1.189e-09
255 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 17 138 6.648e-11 1.213e-09
256 REGULATION OF MUSCLE TISSUE DEVELOPMENT 15 103 8.004e-11 1.449e-09
257 REGULATION OF MUSCLE ORGAN DEVELOPMENT 15 103 8.004e-11 1.449e-09
258 EYE DEVELOPMENT 25 326 8.479e-11 1.529e-09
259 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 9 25 8.962e-11 1.61e-09
260 ENDOTHELIAL CELL DIFFERENTIATION 13 72 9.19e-11 1.645e-09
261 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 18 162 1.032e-10 1.84e-09
262 SINGLE ORGANISM BEHAVIOR 27 384 1.045e-10 1.855e-09
263 REGULATION OF CHONDROCYTE DIFFERENTIATION 11 46 1.05e-10 1.858e-09
264 LEUKOCYTE ACTIVATION 28 414 1.142e-10 2.014e-09
265 LEUKOCYTE CELL CELL ADHESION 22 255 1.262e-10 2.216e-09
266 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 17 144 1.316e-10 2.302e-09
267 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 12 60 1.396e-10 2.433e-09
268 MUSCLE SYSTEM PROCESS 23 282 1.461e-10 2.537e-09
269 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 32 541 1.591e-10 2.742e-09
270 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 32 541 1.591e-10 2.742e-09
271 DIGESTIVE TRACT MORPHOGENESIS 11 48 1.729e-10 2.969e-09
272 NEGATIVE REGULATION OF PHOSPHORYLATION 28 422 1.775e-10 3.036e-09
273 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 21 236 1.898e-10 3.235e-09
274 MUSCLE CELL DEVELOPMENT 16 128 1.957e-10 3.323e-09
275 NEURON MIGRATION 15 110 2.087e-10 3.531e-09
276 PHOSPHORYLATION 51 1228 2.125e-10 3.583e-09
277 DEVELOPMENTAL MATURATION 19 193 2.545e-10 4.276e-09
278 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 34 616 2.577e-10 4.313e-09
279 REGULATION OF CELLULAR PROTEIN LOCALIZATION 32 552 2.644e-10 4.41e-09
280 LEUKOCYTE DIFFERENTIATION 23 292 2.918e-10 4.849e-09
281 EAR DEVELOPMENT 19 195 3.039e-10 5.032e-09
282 OVULATION CYCLE 15 113 3.079e-10 5.062e-09
283 REGULATION OF CELL SUBSTRATE ADHESION 18 173 3.072e-10 5.062e-09
284 REGULATION OF MUSCLE CELL DIFFERENTIATION 17 152 3.106e-10 5.09e-09
285 SECRETION 33 588 3.145e-10 5.134e-09
286 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 37 724 3.435e-10 5.589e-09
287 HOMEOSTASIS OF NUMBER OF CELLS 18 175 3.712e-10 6.019e-09
288 REGULATION OF ION TRANSPORT 33 592 3.741e-10 6.044e-09
289 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 15 115 3.963e-10 6.336e-09
290 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 28 437 3.94e-10 6.336e-09
291 CELLULAR RESPONSE TO ALCOHOL 15 115 3.963e-10 6.336e-09
292 RESPONSE TO CORTICOSTEROID 18 176 4.077e-10 6.496e-09
293 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 16 135 4.378e-10 6.953e-09
294 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 14 98 4.489e-10 7.104e-09
295 NEGATIVE REGULATION OF CELL ADHESION 20 223 4.518e-10 7.126e-09
296 REPRODUCTION 52 1297 4.796e-10 7.538e-09
297 GLIAL CELL DIFFERENTIATION 16 136 4.892e-10 7.664e-09
298 REGULATION OF ANATOMICAL STRUCTURE SIZE 29 472 5.025e-10 7.82e-09
299 KIDNEY MORPHOGENESIS 13 82 5.019e-10 7.82e-09
300 HINDBRAIN DEVELOPMENT 16 137 5.46e-10 8.469e-09
301 CELLULAR RESPONSE TO NITROGEN COMPOUND 30 505 5.553e-10 8.584e-09
302 CELLULAR CHEMICAL HOMEOSTASIS 32 570 5.897e-10 9.085e-09
303 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 19 203 6.039e-10 9.274e-09
304 CELL SUBSTRATE JUNCTION ASSEMBLY 10 41 6.113e-10 9.357e-09
305 RESPONSE TO METAL ION 24 333 7.225e-10 1.102e-08
306 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 14 102 7.73e-10 1.174e-08
307 POSITIVE REGULATION OF AXONOGENESIS 12 69 7.747e-10 1.174e-08
308 POSITIVE REGULATION OF MAP KINASE ACTIVITY 19 207 8.41e-10 1.27e-08
309 CELL CHEMOTAXIS 17 162 8.447e-10 1.272e-08
310 REGULATION OF CALCIUM ION IMPORT 14 103 8.82e-10 1.324e-08
311 SECRETION BY CELL 29 486 9.87e-10 1.476e-08
312 LYMPHOCYTE DIFFERENTIATION 19 209 9.895e-10 1.476e-08
313 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 14 104 1.005e-09 1.494e-08
314 REGULATION OF TRANSMEMBRANE TRANSPORT 27 426 1.043e-09 1.545e-08
315 NEGATIVE REGULATION OF GROWTH 20 236 1.226e-09 1.81e-08
316 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 21 262 1.292e-09 1.903e-08
317 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 22 289 1.367e-09 2.006e-08
318 POSITIVE REGULATION OF GROWTH 20 238 1.42e-09 2.072e-08
319 TRABECULA FORMATION 8 23 1.418e-09 2.072e-08
320 REGULATION OF ORGANELLE ORGANIZATION 48 1178 1.464e-09 2.128e-08
321 PLATELET DEGRANULATION 14 107 1.473e-09 2.135e-08
322 SENSORY ORGAN MORPHOGENESIS 20 239 1.528e-09 2.208e-08
323 CHEMICAL HOMEOSTASIS 40 874 1.577e-09 2.272e-08
324 ENSHEATHMENT OF NEURONS 13 91 1.899e-09 2.719e-08
325 AXON ENSHEATHMENT 13 91 1.899e-09 2.719e-08
326 REGULATION OF CYTOSKELETON ORGANIZATION 29 502 2.069e-09 2.953e-08
327 FORMATION OF PRIMARY GERM LAYER 14 110 2.132e-09 3.034e-08
328 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 13 92 2.181e-09 3.094e-08
329 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 32 602 2.26e-09 3.196e-08
330 NEGATIVE REGULATION OF MOLECULAR FUNCTION 45 1079 2.506e-09 3.533e-08
331 CELLULAR HOMEOSTASIS 34 676 2.834e-09 3.984e-08
332 REGULATION OF BMP SIGNALING PATHWAY 12 77 2.885e-09 4.043e-08
333 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 21 274 2.895e-09 4.045e-08
334 REGULATED EXOCYTOSIS 19 224 3.161e-09 4.404e-08
335 FOREBRAIN CELL MIGRATION 11 62 3.196e-09 4.425e-08
336 CARDIAC VENTRICLE MORPHOGENESIS 11 62 3.196e-09 4.425e-08
337 RENAL TUBULE DEVELOPMENT 12 78 3.362e-09 4.642e-08
338 BONE DEVELOPMENT 16 156 3.735e-09 5.142e-08
339 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 21 278 3.751e-09 5.148e-08
340 CELL GROWTH 15 135 3.828e-09 5.239e-08
341 TELENCEPHALON DEVELOPMENT 19 228 4.239e-09 5.785e-08
342 REGULATION OF DEFENSE RESPONSE 36 759 4.416e-09 6.007e-08
343 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 12 80 4.534e-09 6.151e-08
344 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 21 282 4.837e-09 6.543e-08
345 REGULATION OF BINDING 21 283 5.151e-09 6.947e-08
346 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 12 81 5.248e-09 7.057e-08
347 HEMOSTASIS 22 311 5.327e-09 7.143e-08
348 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 24 370 5.836e-09 7.802e-08
349 REGENERATION 16 161 5.912e-09 7.883e-08
350 RESPONSE TO DRUG 26 431 6.028e-09 8.014e-08
351 CELLULAR MACROMOLECULE LOCALIZATION 48 1234 6.53e-09 8.656e-08
352 PEPTIDYL TYROSINE MODIFICATION 17 186 7.058e-09 9.329e-08
353 TRABECULA MORPHOGENESIS 9 39 7.654e-09 1.006e-07
354 REGULATION OF GRANULOCYTE CHEMOTAXIS 9 39 7.654e-09 1.006e-07
355 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 25 406 7.936e-09 1.04e-07
356 REGULATION OF GTPASE ACTIVITY 33 673 9.165e-09 1.198e-07
357 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 44 1087 9.424e-09 1.228e-07
358 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 17 190 9.731e-09 1.265e-07
359 KIDNEY VASCULATURE DEVELOPMENT 7 19 9.85e-09 1.273e-07
360 RENAL SYSTEM VASCULATURE DEVELOPMENT 7 19 9.85e-09 1.273e-07
361 REGULATION OF IMMUNE RESPONSE 38 858 1.019e-08 1.314e-07
362 NEGATIVE REGULATION OF OSSIFICATION 11 69 1.039e-08 1.336e-07
363 REGULATION OF SYSTEM PROCESS 28 507 1.059e-08 1.357e-07
364 RESPONSE TO ESTRADIOL 15 146 1.129e-08 1.444e-07
365 POSITIVE REGULATION OF CELL CELL ADHESION 19 243 1.206e-08 1.538e-07
366 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 11 70 1.216e-08 1.546e-07
367 SPINAL CORD DEVELOPMENT 13 106 1.275e-08 1.608e-07
368 REGULATION OF WOUND HEALING 14 126 1.275e-08 1.608e-07
369 CARDIAC VENTRICLE DEVELOPMENT 13 106 1.275e-08 1.608e-07
370 NEGATIVE REGULATION OF CELL GROWTH 16 170 1.296e-08 1.629e-07
371 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 33 684 1.357e-08 1.702e-07
372 REGULATION OF STEM CELL PROLIFERATION 12 88 1.381e-08 1.727e-07
373 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 18 220 1.456e-08 1.816e-07
374 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 31 616 1.464e-08 1.822e-07
375 REGULATION OF LEUKOCYTE MIGRATION 15 149 1.491e-08 1.85e-07
376 MODULATION OF SYNAPTIC TRANSMISSION 21 301 1.525e-08 1.887e-07
377 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 9 42 1.545e-08 1.907e-07
378 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 10 56 1.574e-08 1.938e-07
379 RESPIRATORY SYSTEM DEVELOPMENT 17 197 1.674e-08 2.055e-07
380 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 15 152 1.956e-08 2.395e-07
381 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 14 131 2.11e-08 2.577e-07
382 AMEBOIDAL TYPE CELL MIGRATION 15 154 2.336e-08 2.837e-07
383 PROTEIN LOCALIZATION 60 1805 2.33e-08 2.837e-07
384 REGULATION OF VESICLE MEDIATED TRANSPORT 26 462 2.488e-08 3.015e-07
385 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 11 75 2.566e-08 3.077e-07
386 GASTRULATION 15 155 2.549e-08 3.077e-07
387 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 11 75 2.566e-08 3.077e-07
388 NEURAL CREST CELL DIFFERENTIATION 11 75 2.566e-08 3.077e-07
389 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 12 93 2.61e-08 3.122e-07
390 POSITIVE REGULATION OF LIPID KINASE ACTIVITY 8 32 2.689e-08 3.199e-07
391 REGULATION OF NEUTROPHIL MIGRATION 8 32 2.689e-08 3.199e-07
392 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 17 204 2.813e-08 3.339e-07
393 SPROUTING ANGIOGENESIS 9 45 2.945e-08 3.487e-07
394 CHONDROCYTE DIFFERENTIATION 10 60 3.153e-08 3.723e-07
395 REGULATION OF HEMOPOIESIS 21 314 3.173e-08 3.738e-07
396 MUSCLE CONTRACTION 18 233 3.542e-08 4.162e-07
397 REGULATION OF PROTEIN IMPORT 16 183 3.694e-08 4.329e-07
398 REGULATION OF LEUKOCYTE CHEMOTAXIS 12 96 3.752e-08 4.387e-07
399 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 13 116 3.828e-08 4.464e-07
400 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 29 573 3.885e-08 4.52e-07
401 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 16 184 3.988e-08 4.628e-07
402 RESPONSE TO FLUID SHEAR STRESS 8 34 4.515e-08 5.226e-07
403 WNT SIGNALING PATHWAY 22 351 4.716e-08 5.431e-07
404 MESODERM DEVELOPMENT 13 118 4.705e-08 5.431e-07
405 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 12 98 4.744e-08 5.45e-07
406 REGULATION OF SYNAPTIC PLASTICITY 14 140 4.94e-08 5.661e-07
407 RESPONSE TO OXIDATIVE STRESS 22 352 4.959e-08 5.669e-07
408 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 17 213 5.312e-08 6.058e-07
409 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 9 48 5.346e-08 6.082e-07
410 CYTOSKELETON ORGANIZATION 36 838 5.545e-08 6.293e-07
411 METANEPHROS DEVELOPMENT 11 81 5.838e-08 6.61e-07
412 METENCEPHALON DEVELOPMENT 12 100 5.964e-08 6.735e-07
413 REGULATION OF PROTEIN KINASE B SIGNALING 13 121 6.362e-08 7.167e-07
414 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 15 166 6.398e-08 7.191e-07
415 GLOMERULUS DEVELOPMENT 9 49 6.459e-08 7.242e-07
416 RESPONSE TO NUTRIENT 16 191 6.73e-08 7.528e-07
417 CELL DEATH 40 1001 6.767e-08 7.551e-07
418 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 13 122 7.021e-08 7.815e-07
419 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 17 218 7.454e-08 8.278e-07
420 REGULATION OF PEPTIDASE ACTIVITY 23 392 7.746e-08 8.582e-07
421 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 9 50 7.768e-08 8.586e-07
422 NEGATIVE REGULATION OF TRANSPORT 25 458 8.407e-08 9.269e-07
423 INOSITOL LIPID MEDIATED SIGNALING 13 124 8.525e-08 9.378e-07
424 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 11 84 8.576e-08 9.389e-07
425 TISSUE MIGRATION 11 84 8.576e-08 9.389e-07
426 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 9 51 9.303e-08 1.016e-06
427 CEREBRAL CORTEX DEVELOPMENT 12 105 1.033e-07 1.125e-06
428 REGULATION OF PROTEIN TARGETING 20 307 1.044e-07 1.135e-06
429 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 12 106 1.148e-07 1.243e-06
430 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 8 38 1.151e-07 1.243e-06
431 MESENCHYME MORPHOGENESIS 8 38 1.151e-07 1.243e-06
432 REGULATION OF ENDOCYTOSIS 16 199 1.19e-07 1.281e-06
433 EXOCYTOSIS 20 310 1.223e-07 1.314e-06
434 REGULATION OF LIPID METABOLIC PROCESS 19 282 1.297e-07 1.391e-06
435 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 22 372 1.305e-07 1.396e-06
436 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 9 53 1.318e-07 1.403e-06
437 MESONEPHRIC TUBULE MORPHOGENESIS 9 53 1.318e-07 1.403e-06
438 REGULATION OF PROTEIN COMPLEX ASSEMBLY 22 375 1.5e-07 1.593e-06
439 PALLIUM DEVELOPMENT 14 153 1.511e-07 1.601e-06
440 ION HOMEOSTASIS 28 576 1.551e-07 1.641e-06
441 POSITIVE REGULATION OF CALCIUM ION IMPORT 9 54 1.56e-07 1.642e-06
442 REGULATION OF NEUTROPHIL CHEMOTAXIS 7 27 1.557e-07 1.642e-06
443 CELL MATURATION 13 131 1.635e-07 1.717e-06
444 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 12 110 1.735e-07 1.818e-06
445 NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 8 40 1.761e-07 1.841e-06
446 PEPTIDYL AMINO ACID MODIFICATION 35 841 1.846e-07 1.926e-06
447 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 14 156 1.924e-07 2.002e-06
448 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 22 381 1.972e-07 2.048e-06
449 AORTA DEVELOPMENT 8 41 2.158e-07 2.226e-06
450 EMBRYONIC HEART TUBE DEVELOPMENT 10 73 2.167e-07 2.226e-06
451 REGULATION OF ORGAN GROWTH 10 73 2.167e-07 2.226e-06
452 OUTFLOW TRACT MORPHOGENESIS 9 56 2.162e-07 2.226e-06
453 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 10 73 2.167e-07 2.226e-06
454 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 16 208 2.184e-07 2.238e-06
455 POSITIVE REGULATION OF ION TRANSPORT 17 236 2.337e-07 2.39e-06
456 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 6 18 2.347e-07 2.395e-06
457 REGULATION OF JNK CASCADE 14 159 2.435e-07 2.48e-06
458 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 74 2.471e-07 2.505e-06
459 CELL CELL JUNCTION ASSEMBLY 10 74 2.471e-07 2.505e-06
460 REGULATION OF INFLAMMATORY RESPONSE 19 294 2.477e-07 2.505e-06
461 POSITIVE REGULATION OF ENDOCYTOSIS 12 114 2.575e-07 2.599e-06
462 POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 8 42 2.63e-07 2.649e-06
463 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 7 29 2.664e-07 2.677e-06
464 SKELETAL MUSCLE ORGAN DEVELOPMENT 13 137 2.764e-07 2.761e-06
465 INFLAMMATORY RESPONSE 24 454 2.764e-07 2.761e-06
466 RESPONSE TO BMP 11 94 2.771e-07 2.761e-06
467 CELLULAR RESPONSE TO BMP STIMULUS 11 94 2.771e-07 2.761e-06
468 MULTI MULTICELLULAR ORGANISM PROCESS 16 213 3.017e-07 3e-06
469 POSITIVE REGULATION OF RESPONSE TO WOUNDING 14 162 3.067e-07 3.042e-06
470 RESPONSE TO FIBROBLAST GROWTH FACTOR 12 116 3.118e-07 3.086e-06
471 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 21 360 3.18e-07 3.142e-06
472 REGULATION OF CELL SHAPE 13 139 3.273e-07 3.227e-06
473 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 30 3.428e-07 3.358e-06
474 ESTABLISHMENT OF ENDOTHELIAL BARRIER 7 30 3.428e-07 3.358e-06
475 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 7 30 3.428e-07 3.358e-06
476 CARDIOCYTE DIFFERENTIATION 11 96 3.441e-07 3.364e-06
477 REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 10 77 3.619e-07 3.53e-06
478 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 34 829 3.922e-07 3.818e-06
479 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 15 191 4.018e-07 3.903e-06
480 SOMITE DEVELOPMENT 10 78 4.093e-07 3.968e-06
481 PLATELET ACTIVATION 13 142 4.194e-07 4.057e-06
482 ENDOTHELIAL CELL DEVELOPMENT 8 45 4.609e-07 4.449e-06
483 REGULATION OF CELLULAR COMPONENT SIZE 20 337 4.656e-07 4.485e-06
484 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 11 99 4.716e-07 4.515e-06
485 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 11 99 4.716e-07 4.515e-06
486 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 11 99 4.716e-07 4.515e-06
487 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 6 20 4.772e-07 4.55e-06
488 LYMPH VESSEL DEVELOPMENT 6 20 4.772e-07 4.55e-06
489 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 13 144 4.93e-07 4.691e-06
490 ADULT LOCOMOTORY BEHAVIOR 10 80 5.209e-07 4.946e-06
491 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 9 62 5.327e-07 5.038e-06
492 EMBRYONIC HEART TUBE MORPHOGENESIS 9 62 5.327e-07 5.038e-06
493 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 22 404 5.349e-07 5.048e-06
494 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 12 122 5.407e-07 5.093e-06
495 PATTERNING OF BLOOD VESSELS 7 32 5.515e-07 5.184e-06
496 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 60 1977 5.57e-07 5.225e-06
497 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 15 197 5.974e-07 5.593e-06
498 REGULATION OF CELLULAR RESPONSE TO STRESS 30 691 6.141e-07 5.738e-06
499 RESPONSE TO EXTRACELLULAR STIMULUS 23 441 6.234e-07 5.813e-06
500 REGULATION OF CATABOLIC PROCESS 31 731 6.524e-07 6.072e-06
501 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 5 12 6.899e-07 6.408e-06
502 REGULATION OF PHOSPHOLIPASE ACTIVITY 9 64 7.034e-07 6.52e-06
503 NEURAL TUBE DEVELOPMENT 13 149 7.299e-07 6.752e-06
504 OSTEOBLAST DIFFERENTIATION 12 126 7.667e-07 7.079e-06
505 REGULATION OF LIPID KINASE ACTIVITY 8 48 7.743e-07 7.134e-06
506 REGULATION OF SECRETION 30 699 7.799e-07 7.172e-06
507 CELLULAR RESPONSE TO ACID CHEMICAL 14 175 7.858e-07 7.183e-06
508 POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 14 175 7.858e-07 7.183e-06
509 IMMUNE RESPONSE 40 1100 7.829e-07 7.183e-06
510 POSITIVE REGULATION OF BINDING 12 127 8.349e-07 7.617e-06
511 ADHERENS JUNCTION ASSEMBLY 7 34 8.579e-07 7.767e-06
512 RESPONSE TO PROSTAGLANDIN 7 34 8.579e-07 7.767e-06
513 HEART VALVE DEVELOPMENT 7 34 8.579e-07 7.767e-06
514 ODONTOGENESIS 11 105 8.571e-07 7.767e-06
515 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 6 22 8.944e-07 8.066e-06
516 AORTA MORPHOGENESIS 6 22 8.944e-07 8.066e-06
517 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 8 49 9.128e-07 8.215e-06
518 REGULATION OF CHROMATIN ORGANIZATION 13 152 9.166e-07 8.234e-06
519 REGULATION OF FAT CELL DIFFERENTIATION 11 106 9.43e-07 8.438e-06
520 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 19 321 9.421e-07 8.438e-06
521 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 16 232 9.489e-07 8.459e-06
522 REGULATION OF LEUKOCYTE DIFFERENTIATION 16 232 9.489e-07 8.459e-06
523 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 13 153 9.877e-07 8.788e-06
524 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 16 233 1.005e-06 8.92e-06
525 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 13 154 1.064e-06 9.427e-06
526 RESPONSE TO PROGESTERONE 8 50 1.072e-06 9.482e-06
527 LYMPH VESSEL MORPHOGENESIS 5 13 1.107e-06 9.743e-06
528 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 5 13 1.107e-06 9.743e-06
529 REGULATION OF PROTEOLYSIS 30 711 1.108e-06 9.743e-06
530 TISSUE REMODELING 10 87 1.148e-06 1.008e-05
531 LOCOMOTORY BEHAVIOR 14 181 1.178e-06 1.033e-05
532 REGULATION OF CELL JUNCTION ASSEMBLY 9 68 1.191e-06 1.04e-05
533 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 9 68 1.191e-06 1.04e-05
534 SEX DIFFERENTIATION 17 266 1.249e-06 1.088e-05
535 OVULATION CYCLE PROCESS 10 88 1.277e-06 1.111e-05
536 POSITIVE REGULATION OF AXON EXTENSION 7 36 1.296e-06 1.125e-05
537 POSITIVE REGULATION OF DEFENSE RESPONSE 20 364 1.546e-06 1.34e-05
538 FOCAL ADHESION ASSEMBLY 6 24 1.571e-06 1.354e-05
539 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 24 1.571e-06 1.354e-05
540 CELL SUBSTRATE ADHERENS JUNCTION ASSEMBLY 6 24 1.571e-06 1.354e-05
541 REGULATION OF CELL MATRIX ADHESION 10 90 1.575e-06 1.354e-05
542 ADULT BEHAVIOR 12 135 1.605e-06 1.378e-05
543 EAR MORPHOGENESIS 11 112 1.637e-06 1.403e-05
544 CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 5 14 1.699e-06 1.44e-05
545 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 5 14 1.699e-06 1.44e-05
546 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 8 53 1.698e-06 1.44e-05
547 HEART TRABECULA FORMATION 5 14 1.699e-06 1.44e-05
548 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 5 14 1.699e-06 1.44e-05
549 CELLULAR RESPONSE TO VITAMIN D 5 14 1.699e-06 1.44e-05
550 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 13 162 1.885e-06 1.594e-05
551 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 7 38 1.907e-06 1.61e-05
552 MYELOID CELL DIFFERENTIATION 14 189 1.972e-06 1.662e-05
553 POSITIVE REGULATION OF HEMOPOIESIS 13 163 2.019e-06 1.696e-05
554 VASCULAR PROCESS IN CIRCULATORY SYSTEM 13 163 2.019e-06 1.696e-05
555 NEGATIVE REGULATION OF CELL CELL ADHESION 12 138 2.025e-06 1.698e-05
556 RESPONSE TO PROSTAGLANDIN E 6 25 2.04e-06 1.707e-05
557 RESPONSE TO PEPTIDE 21 404 2.044e-06 1.708e-05
558 CELLULAR RESPONSE TO KETONE 9 73 2.189e-06 1.826e-05
559 RESPONSE TO REACTIVE OXYGEN SPECIES 14 191 2.233e-06 1.859e-05
560 CRANIAL SKELETAL SYSTEM DEVELOPMENT 8 55 2.27e-06 1.886e-05
561 REGULATION OF PHOSPHOLIPASE C ACTIVITY 7 39 2.292e-06 1.891e-05
562 LONG TERM SYNAPTIC POTENTIATION 7 39 2.292e-06 1.891e-05
563 NEGATIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 7 39 2.292e-06 1.891e-05
564 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 7 39 2.292e-06 1.891e-05
565 FEMALE SEX DIFFERENTIATION 11 116 2.318e-06 1.909e-05
566 VESICLE MEDIATED TRANSPORT 42 1239 2.472e-06 2.032e-05
567 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 5 15 2.516e-06 2.065e-05
568 MAMMARY GLAND DEVELOPMENT 11 117 2.523e-06 2.067e-05
569 REGULATION OF HEART CONTRACTION 15 221 2.534e-06 2.072e-05
570 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 10 95 2.594e-06 2.118e-05
571 HEART TRABECULA MORPHOGENESIS 6 26 2.617e-06 2.125e-05
572 EPITHELIAL TO MESENCHYMAL TRANSITION 8 56 2.612e-06 2.125e-05
573 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 6 26 2.617e-06 2.125e-05
574 COGNITION 16 251 2.66e-06 2.156e-05
575 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 7 40 2.741e-06 2.218e-05
576 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 12 143 2.946e-06 2.38e-05
577 PROSTATE GLAND DEVELOPMENT 7 41 3.261e-06 2.63e-05
578 POSITIVE REGULATION OF NEUTROPHIL MIGRATION 6 27 3.32e-06 2.659e-05
579 SUBSTRATE DEPENDENT CELL MIGRATION 6 27 3.32e-06 2.659e-05
580 AXIS ELONGATION 6 27 3.32e-06 2.659e-05
581 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 6 27 3.32e-06 2.659e-05
582 ACTOMYOSIN STRUCTURE ORGANIZATION 9 77 3.443e-06 2.748e-05
583 DEVELOPMENTAL CELL GROWTH 9 77 3.443e-06 2.748e-05
584 RESPONSE TO VITAMIN 10 98 3.449e-06 2.748e-05
585 EXTRACELLULAR MATRIX ASSEMBLY 5 16 3.612e-06 2.873e-05
586 REGULATION OF CYTOKINE PRODUCTION 25 563 3.724e-06 2.957e-05
587 MYELOID LEUKOCYTE MIGRATION 10 99 3.783e-06 2.994e-05
588 LIPID PHOSPHORYLATION 10 99 3.783e-06 2.994e-05
589 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 7 42 3.861e-06 3.045e-05
590 REGULATION OF HEART GROWTH 7 42 3.861e-06 3.045e-05
591 T CELL DIFFERENTIATION 11 123 4.121e-06 3.245e-05
592 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 10 100 4.146e-06 3.258e-05
593 POSITIVE REGULATION OF CELL GROWTH 12 148 4.216e-06 3.308e-05
594 REGULATION OF PROTEIN SECRETION 20 389 4.234e-06 3.317e-05
595 DENDRITE DEVELOPMENT 9 79 4.272e-06 3.341e-05
596 STEM CELL PROLIFERATION 8 60 4.454e-06 3.476e-05
597 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 11 124 4.459e-06 3.476e-05
598 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 43 4.55e-06 3.54e-05
599 RESPONSE TO BIOTIC STIMULUS 33 886 4.736e-06 3.679e-05
600 REGULATION OF PROTEIN CATABOLIC PROCESS 20 393 4.933e-06 3.826e-05
601 EMBRYONIC DIGIT MORPHOGENESIS 8 61 5.057e-06 3.894e-05
602 REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 8 61 5.057e-06 3.894e-05
603 REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 5 17 5.051e-06 3.894e-05
604 NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 5 17 5.051e-06 3.894e-05
605 REGULATION OF BLOOD CIRCULATION 17 295 5.063e-06 3.894e-05
606 CELLULAR RESPONSE TO EXTERNAL STIMULUS 16 264 5.086e-06 3.905e-05
607 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 6 29 5.188e-06 3.977e-05
608 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 7 44 5.338e-06 4.085e-05
609 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 13 179 5.695e-06 4.351e-05
610 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 20 397 5.735e-06 4.375e-05
611 RHYTHMIC PROCESS 17 298 5.79e-06 4.41e-05
612 POSITIVE REGULATION OF PROTEIN IMPORT 10 104 5.913e-06 4.495e-05
613 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 11 128 6.068e-06 4.606e-05
614 EXOCRINE SYSTEM DEVELOPMENT 7 45 6.236e-06 4.726e-05
615 SMOOTH MUSCLE CELL DIFFERENTIATION 6 30 6.399e-06 4.841e-05
616 REGULATION OF LIPASE ACTIVITY 9 83 6.456e-06 4.869e-05
617 RESPONSE TO FATTY ACID 9 83 6.456e-06 4.869e-05
618 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 11 129 6.542e-06 4.925e-05
619 SMOOTH MUSCLE TISSUE DEVELOPMENT 5 18 6.903e-06 5.189e-05
620 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 12 156 7.261e-06 5.44e-05
621 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 12 156 7.261e-06 5.44e-05
622 REGULATION OF PROTEIN ACETYLATION 8 64 7.295e-06 5.457e-05
623 RESPONSE TO RETINOIC ACID 10 107 7.635e-06 5.702e-05
624 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 23 514 8.122e-06 6.056e-05
625 REGULATION OF LYMPHOCYTE DIFFERENTIATION 11 132 8.161e-06 6.076e-05
626 POSITIVE REGULATION OF DEPHOSPHORYLATION 7 47 8.412e-06 6.252e-05
627 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 15 245 8.892e-06 6.599e-05
628 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 10 109 9.01e-06 6.665e-05
629 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 10 109 9.01e-06 6.665e-05
630 FOREBRAIN GENERATION OF NEURONS 8 66 9.211e-06 6.792e-05
631 MESODERM MORPHOGENESIS 8 66 9.211e-06 6.792e-05
632 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 5 19 9.248e-06 6.798e-05
633 FIBRIL ORGANIZATION 5 19 9.248e-06 6.798e-05
634 SALIVARY GLAND DEVELOPMENT 6 32 9.509e-06 6.946e-05
635 ENDOCARDIAL CUSHION DEVELOPMENT 6 32 9.509e-06 6.946e-05
636 NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 6 32 9.509e-06 6.946e-05
637 METANEPHRIC NEPHRON DEVELOPMENT 6 32 9.509e-06 6.946e-05
638 MYOFIBRIL ASSEMBLY 7 48 9.716e-06 7.075e-05
639 POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 7 48 9.716e-06 7.075e-05
640 REGULATION OF MEMBRANE POTENTIAL 18 343 9.733e-06 7.076e-05
641 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 14 218 1.033e-05 7.497e-05
642 REGULATION OF COAGULATION 9 88 1.047e-05 7.58e-05
643 ESTABLISHMENT OF CELL POLARITY 9 88 1.047e-05 7.58e-05
644 RESPONSE TO ETHANOL 11 136 1.086e-05 7.845e-05
645 CARDIAC CELL DEVELOPMENT 7 49 1.118e-05 8.067e-05
646 RESPONSE TO VITAMIN D 6 33 1.147e-05 8.261e-05
647 SEGMENTATION 9 89 1.149e-05 8.266e-05
648 ORGAN GROWTH 8 68 1.153e-05 8.282e-05
649 REGULATION OF GLIOGENESIS 9 90 1.26e-05 9.03e-05
650 RECEPTOR INTERNALIZATION 7 50 1.283e-05 9.17e-05
651 ENDODERM FORMATION 7 50 1.283e-05 9.17e-05
652 CALCIUM ION TRANSPORT 14 223 1.335e-05 9.527e-05
653 FOREBRAIN NEURON DEVELOPMENT 6 34 1.374e-05 9.778e-05
654 REGULATION OF MESENCHYMAL CELL PROLIFERATION 6 34 1.374e-05 9.778e-05
655 MULTICELLULAR ORGANISM REPRODUCTION 29 768 1.426e-05 0.0001013
656 CARDIAC MUSCLE TISSUE DEVELOPMENT 11 140 1.43e-05 0.0001014
657 NEGATIVE REGULATION OF CHEMOTAXIS 7 51 1.467e-05 0.0001039
658 REGULATION OF IMMUNE EFFECTOR PROCESS 20 424 1.503e-05 0.0001063
659 INNER EAR MORPHOGENESIS 9 92 1.507e-05 0.0001064
660 METANEPHRIC NEPHRON MORPHOGENESIS 5 21 1.577e-05 0.0001105
661 CELL AGGREGATION 5 21 1.577e-05 0.0001105
662 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 5 21 1.577e-05 0.0001105
663 CARTILAGE CONDENSATION 5 21 1.577e-05 0.0001105
664 RESPONSE TO NITRIC OXIDE 5 21 1.577e-05 0.0001105
665 ENDODERM DEVELOPMENT 8 71 1.593e-05 0.0001113
666 CELL FATE SPECIFICATION 8 71 1.593e-05 0.0001113
667 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 13 197 1.601e-05 0.0001117
668 REGULATION OF BLOOD PRESSURE 12 169 1.636e-05 0.0001136
669 APPENDAGE DEVELOPMENT 12 169 1.636e-05 0.0001136
670 LIMB DEVELOPMENT 12 169 1.636e-05 0.0001136
671 REGULATION OF DNA BINDING 9 93 1.646e-05 0.0001141
672 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 7 52 1.673e-05 0.0001158
673 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 10 117 1.687e-05 0.0001164
674 SPECIFICATION OF SYMMETRY 10 117 1.687e-05 0.0001164
675 RAS PROTEIN SIGNAL TRANSDUCTION 11 143 1.746e-05 0.0001204
676 SMOOTHENED SIGNALING PATHWAY 8 72 1.768e-05 0.0001217
677 LYMPHANGIOGENESIS 4 11 1.849e-05 0.0001269
678 OLFACTORY BULB INTERNEURON DEVELOPMENT 4 11 1.849e-05 0.0001269
679 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 7 53 1.901e-05 0.0001299
680 MAMMARY GLAND EPITHELIUM DEVELOPMENT 7 53 1.901e-05 0.0001299
681 CYTOSOLIC CALCIUM ION TRANSPORT 7 53 1.901e-05 0.0001299
682 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 6 36 1.938e-05 0.0001313
683 REGULATION OF ERYTHROCYTE DIFFERENTIATION 6 36 1.938e-05 0.0001313
684 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 6 36 1.938e-05 0.0001313
685 NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 6 36 1.938e-05 0.0001313
686 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 6 36 1.938e-05 0.0001313
687 T CELL SELECTION 6 36 1.938e-05 0.0001313
688 REGULATION OF CELL SIZE 12 172 1.951e-05 0.000132
689 CANONICAL WNT SIGNALING PATHWAY 9 95 1.956e-05 0.0001321
690 SYNAPSE ORGANIZATION 11 145 1.99e-05 0.000134
691 NEGATIVE REGULATION OF MAPK CASCADE 11 145 1.99e-05 0.000134
692 REGULATION OF CELLULAR EXTRAVASATION 5 22 2.014e-05 0.0001353
693 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 5 22 2.014e-05 0.0001353
694 REGULATION OF PROTEIN POLYMERIZATION 12 173 2.068e-05 0.0001386
695 POSITIVE REGULATION OF PROTEOLYSIS 18 363 2.084e-05 0.0001395
696 REGULATION OF DENDRITE DEVELOPMENT 10 120 2.105e-05 0.0001407
697 CARDIAC MUSCLE CELL DIFFERENTIATION 8 74 2.167e-05 0.0001446
698 REGULATION OF MUSCLE CONTRACTION 11 147 2.262e-05 0.0001507
699 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 10 121 2.263e-05 0.0001507
700 AXON EXTENSION 6 37 2.283e-05 0.0001517
701 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 9 97 2.314e-05 0.0001536
702 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 8 75 2.392e-05 0.0001586
703 RESPONSE TO TRANSITION METAL NANOPARTICLE 11 148 2.409e-05 0.0001595
704 REGULATION OF KIDNEY DEVELOPMENT 7 55 2.436e-05 0.000161
705 PROSTATE GLAND MORPHOGENESIS 5 23 2.541e-05 0.000167
706 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 5 23 2.541e-05 0.000167
707 REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 5 23 2.541e-05 0.000167
708 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 5 23 2.541e-05 0.000167
709 GLIAL CELL DEVELOPMENT 8 76 2.638e-05 0.0001731
710 COLLAGEN FIBRIL ORGANIZATION 6 38 2.675e-05 0.0001751
711 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 38 2.675e-05 0.0001751
712 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 4 12 2.739e-05 0.0001782
713 CARTILAGE MORPHOGENESIS 4 12 2.739e-05 0.0001782
714 AXON EXTENSION INVOLVED IN AXON GUIDANCE 4 12 2.739e-05 0.0001782
715 HEMATOPOIETIC STEM CELL DIFFERENTIATION 4 12 2.739e-05 0.0001782
716 DIENCEPHALON DEVELOPMENT 8 77 2.903e-05 0.0001887
717 LIMBIC SYSTEM DEVELOPMENT 9 100 2.956e-05 0.0001918
718 ENDOTHELIAL CELL MIGRATION 7 57 3.09e-05 0.0001997
719 MYOTUBE DIFFERENTIATION 7 57 3.09e-05 0.0001997
720 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 11 152 3.087e-05 0.0001997
721 POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 6 39 3.12e-05 0.0002005
722 ANATOMICAL STRUCTURE MATURATION 6 39 3.12e-05 0.0002005
723 CELLULAR RESPONSE TO NUTRIENT 6 39 3.12e-05 0.0002005
724 PLATELET AGGREGATION 6 39 3.12e-05 0.0002005
725 SPINAL CORD PATTERNING 5 24 3.168e-05 0.000203
726 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 5 24 3.168e-05 0.000203
727 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 9 101 3.2e-05 0.0002048
728 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 11 153 3.28e-05 0.0002096
729 NEGATIVE REGULATION OF ION TRANSPORT 10 127 3.442e-05 0.0002197
730 CELL CYCLE ARREST 11 154 3.483e-05 0.000222
731 BONE MORPHOGENESIS 8 79 3.503e-05 0.000223
732 MAMMARY GLAND MORPHOGENESIS 6 40 3.622e-05 0.000229
733 POSITIVE REGULATION OF CELL MATRIX ADHESION 6 40 3.622e-05 0.000229
734 REGULATION OF MYELOID CELL DIFFERENTIATION 12 183 3.605e-05 0.000229
735 DEVELOPMENTAL PIGMENTATION 6 40 3.622e-05 0.000229
736 HINDBRAIN MORPHOGENESIS 6 40 3.622e-05 0.000229
737 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 13 213 3.64e-05 0.0002298
738 REGULATION OF CELL PROJECTION ASSEMBLY 11 155 3.698e-05 0.0002331
739 RESPONSE TO BACTERIUM 22 528 3.792e-05 0.0002387
740 CELLULAR RESPONSE TO OXIDATIVE STRESS 12 184 3.803e-05 0.0002391
741 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 8 80 3.839e-05 0.0002411
742 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 7 59 3.881e-05 0.000243
743 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 7 59 3.881e-05 0.000243
744 REGULATION OF VASCULOGENESIS 4 13 3.906e-05 0.0002435
745 CELLULAR EXTRAVASATION 5 25 3.909e-05 0.0002435
746 NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 4 13 3.906e-05 0.0002435
747 REGULATION OF CELL FATE SPECIFICATION 4 13 3.906e-05 0.0002435
748 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 11 156 3.923e-05 0.000244
749 ACTIVATION OF PROTEIN KINASE ACTIVITY 15 279 4.077e-05 0.0002533
750 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 6 41 4.187e-05 0.0002598
751 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 8 81 4.202e-05 0.0002604
752 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 13 216 4.208e-05 0.0002604
753 RESPONSE TO PURINE CONTAINING COMPOUND 11 158 4.41e-05 0.0002725
754 RETINA DEVELOPMENT IN CAMERA TYPE EYE 10 131 4.491e-05 0.0002772
755 RECEPTOR METABOLIC PROCESS 8 82 4.594e-05 0.0002831
756 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 12 188 4.692e-05 0.0002888
757 NEGATIVE REGULATION OF KINASE ACTIVITY 14 250 4.731e-05 0.0002908
758 REGULATION OF MESONEPHROS DEVELOPMENT 5 26 4.778e-05 0.0002929
759 CELLULAR RESPONSE TO VITAMIN 5 26 4.778e-05 0.0002929
760 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 6 42 4.82e-05 0.0002932
761 POSITIVE REGULATION OF DNA BINDING 6 42 4.82e-05 0.0002932
762 DENDRITE MORPHOGENESIS 6 42 4.82e-05 0.0002932
763 MAINTENANCE OF CELL NUMBER 10 132 4.792e-05 0.0002932
764 EPITHELIAL CELL MORPHOGENESIS 6 42 4.82e-05 0.0002932
765 CALCIUM ION IMPORT INTO CYTOSOL 6 42 4.82e-05 0.0002932
766 REGULATION OF T CELL DIFFERENTIATION 9 107 5.059e-05 0.0003073
767 REGULATION OF PROTEIN STABILITY 13 221 5.327e-05 0.0003231
768 SOMITOGENESIS 7 62 5.372e-05 0.0003251
769 REGULATION OF SMOOTHENED SIGNALING PATHWAY 7 62 5.372e-05 0.0003251
770 POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 4 14 5.401e-05 0.0003251
771 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 4 14 5.401e-05 0.0003251
772 CRANIOFACIAL SUTURE MORPHOGENESIS 4 14 5.401e-05 0.0003251
773 ANGIOGENESIS INVOLVED IN WOUND HEALING 4 14 5.401e-05 0.0003251
774 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 6 43 5.528e-05 0.0003319
775 CEREBRAL CORTEX CELL MIGRATION 6 43 5.528e-05 0.0003319
776 REGULATION OF ASTROCYTE DIFFERENTIATION 5 27 5.788e-05 0.0003466
777 MOTOR NEURON AXON GUIDANCE 5 27 5.788e-05 0.0003466
778 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 10 135 5.802e-05 0.000347
779 CARDIAC SEPTUM DEVELOPMENT 8 85 5.954e-05 0.0003556
780 DEFENSE RESPONSE 38 1231 6.076e-05 0.0003624
781 EYE MORPHOGENESIS 10 136 6.176e-05 0.0003679
782 BODY MORPHOGENESIS 6 44 6.317e-05 0.0003759
783 PIGMENTATION 8 86 6.476e-05 0.0003843
784 REGULATION OF HEART RATE 8 86 6.476e-05 0.0003843
785 NEGATIVE REGULATION OF CELL CYCLE 19 433 6.515e-05 0.0003862
786 ENDOCYTOSIS 21 509 6.551e-05 0.0003878
787 ACTIVATION OF MAPK ACTIVITY 10 137 6.571e-05 0.0003885
788 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 14 258 6.646e-05 0.0003924
789 REGULATION OF MUSCLE SYSTEM PROCESS 12 195 6.684e-05 0.0003942
790 REGULATION OF FIBROBLAST MIGRATION 5 28 6.956e-05 0.0004076
791 PLACENTA BLOOD VESSEL DEVELOPMENT 5 28 6.956e-05 0.0004076
792 REGULATION OF SPROUTING ANGIOGENESIS 5 28 6.956e-05 0.0004076
793 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 5 28 6.956e-05 0.0004076
794 METANEPHROS MORPHOGENESIS 5 28 6.956e-05 0.0004076
795 MAINTENANCE OF LOCATION 10 138 6.986e-05 0.0004089
796 THYMOCYTE AGGREGATION 6 45 7.193e-05 0.0004189
797 T CELL DIFFERENTIATION IN THYMUS 6 45 7.193e-05 0.0004189
798 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 6 45 7.193e-05 0.0004189
799 REGULATION OF APOPTOTIC SIGNALING PATHWAY 17 363 7.173e-05 0.0004189
800 OLFACTORY BULB INTERNEURON DIFFERENTIATION 4 15 7.274e-05 0.0004215
801 MESENCHYMAL TO EPITHELIAL TRANSITION 4 15 7.274e-05 0.0004215
802 ENDOCARDIAL CUSHION FORMATION 4 15 7.274e-05 0.0004215
803 NEPHRIC DUCT DEVELOPMENT 4 15 7.274e-05 0.0004215
804 CELLULAR RESPONSE TO RETINOIC ACID 7 65 7.304e-05 0.0004222
805 CALCIUM ION IMPORT 7 65 7.304e-05 0.0004222
806 RESPONSE TO ORGANOPHOSPHORUS 10 139 7.424e-05 0.0004286
807 MYELOID CELL HOMEOSTASIS 8 88 7.633e-05 0.0004396
808 LEUKOCYTE PROLIFERATION 8 88 7.633e-05 0.0004396
809 REGULATION OF PROTEIN BINDING 11 168 7.699e-05 0.0004423
810 RESPONSE TO CARBOHYDRATE 11 168 7.699e-05 0.0004423
811 CELLULAR COMPONENT DISASSEMBLY 21 515 7.731e-05 0.0004436
812 REGULATION OF STEM CELL DIFFERENTIATION 9 113 7.756e-05 0.0004445
813 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 7 66 8.061e-05 0.0004602
814 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 7 66 8.061e-05 0.0004602
815 POSITIVE REGULATION OF LIPASE ACTIVITY 7 66 8.061e-05 0.0004602
816 REGULATION OF HORMONE LEVELS 20 478 8.074e-05 0.0004604
817 CELLULAR RESPONSE TO ABIOTIC STIMULUS 14 263 8.16e-05 0.0004643
818 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 6 46 8.163e-05 0.0004643
819 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 5 29 8.297e-05 0.0004702
820 REGULATION OF HEART MORPHOGENESIS 5 29 8.297e-05 0.0004702
821 PIGMENT CELL DIFFERENTIATION 5 29 8.297e-05 0.0004702
822 NOTCH SIGNALING PATHWAY 9 114 8.306e-05 0.0004702
823 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 10 141 8.371e-05 0.0004733
824 NEGATIVE REGULATION OF SECRETION 12 200 8.519e-05 0.0004811
825 REGULATION OF OXIDOREDUCTASE ACTIVITY 8 90 8.958e-05 0.0005052
826 MUSCLE FIBER DEVELOPMENT 6 47 9.234e-05 0.0005202
827 CELLULAR RESPONSE TO OXYGEN LEVELS 10 143 9.418e-05 0.0005299
828 DENDRITIC CELL CHEMOTAXIS 4 16 9.578e-05 0.000535
829 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 4 16 9.578e-05 0.000535
830 NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 4 16 9.578e-05 0.000535
831 POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 4 16 9.578e-05 0.000535
832 ATRIOVENTRICULAR VALVE MORPHOGENESIS 4 16 9.578e-05 0.000535
833 NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 4 16 9.578e-05 0.000535
834 POSITIVE REGULATION OF IMMUNE RESPONSE 22 563 9.721e-05 0.0005423
835 MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 7 68 9.768e-05 0.0005437
836 NERVE DEVELOPMENT 7 68 9.768e-05 0.0005437
837 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 5 30 9.828e-05 0.0005463
838 DIVALENT INORGANIC CATION TRANSPORT 14 268 9.966e-05 0.0005534
839 LEUKOCYTE CHEMOTAXIS 9 117 0.0001016 0.0005632
840 REGULATION OF MYOBLAST DIFFERENTIATION 6 48 0.0001041 0.0005755
841 POSITIVE REGULATION OF WOUND HEALING 6 48 0.0001041 0.0005755
842 REGULATION OF INTERLEUKIN 2 PRODUCTION 6 48 0.0001041 0.0005755
843 ACTIN FILAMENT ORGANIZATION 11 174 0.0001054 0.0005819
844 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 9 118 0.0001084 0.0005979
845 REGULATION OF LEUKOCYTE PROLIFERATION 12 206 0.0001128 0.0006212
846 POSITIVE REGULATION OF BLOOD CIRCULATION 8 93 0.000113 0.0006214
847 ADULT WALKING BEHAVIOR 5 31 0.0001157 0.000634
848 CARDIAC ATRIUM DEVELOPMENT 5 31 0.0001157 0.000634
849 WALKING BEHAVIOR 5 31 0.0001157 0.000634
850 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 6 49 0.0001171 0.0006404
851 LYMPHOCYTE MIGRATION 6 49 0.0001171 0.0006404
852 MUSCLE ORGAN MORPHOGENESIS 7 70 0.0001176 0.0006422
853 BRANCH ELONGATION OF AN EPITHELIUM 4 17 0.0001237 0.0006716
854 CYTOKINE PRODUCTION 9 120 0.0001234 0.0006716
855 NEGATIVE REGULATION OF ANOIKIS 4 17 0.0001237 0.0006716
856 MYELIN ASSEMBLY 4 17 0.0001237 0.0006716
857 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 4 17 0.0001237 0.0006716
858 CELL RECOGNITION 10 148 0.0001253 0.0006795
859 CELLULAR RESPONSE TO PEPTIDE 14 274 0.0001258 0.0006816
860 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 12 209 0.0001293 0.0006995
861 FACE DEVELOPMENT 6 50 0.0001313 0.0007098
862 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 5 32 0.0001353 0.0007297
863 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 5 32 0.0001353 0.0007297
864 MYELOID LEUKOCYTE DIFFERENTIATION 8 96 0.0001412 0.0007605
865 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 12 211 0.0001414 0.0007605
866 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 6 51 0.0001469 0.0007865
867 NEGATIVE REGULATION OF CALCIUM ION TRANSPORT 6 51 0.0001469 0.0007865
868 HOMOTYPIC CELL CELL ADHESION 6 51 0.0001469 0.0007865
869 REGULATION OF CHROMOSOME ORGANIZATION 14 278 0.0001464 0.0007865
870 ENDOCRINE SYSTEM DEVELOPMENT 9 123 0.000149 0.000797
871 ERYTHROCYTE HOMEOSTASIS 7 73 0.0001535 0.00082
872 NEUROLOGICAL SYSTEM PROCESS 37 1242 0.0001568 0.0008352
873 RETINAL GANGLION CELL AXON GUIDANCE 4 18 0.0001571 0.0008352
874 ATRIAL SEPTUM DEVELOPMENT 4 18 0.0001571 0.0008352
875 CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 13 246 0.0001568 0.0008352
876 DENDRITIC CELL DIFFERENTIATION 5 33 0.0001575 0.0008363
877 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 8 98 0.0001631 0.0008653
878 TISSUE REGENERATION 6 52 0.0001639 0.0008685
879 REGULATION OF DENDRITE MORPHOGENESIS 7 74 0.0001673 0.0008845
880 ACTIN MEDIATED CELL CONTRACTION 7 74 0.0001673 0.0008845
881 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 12 216 0.0001759 0.0009292
882 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 9 126 0.0001789 0.000944
883 NEURON PROJECTION EXTENSION 6 53 0.0001824 0.0009566
884 ORGAN FORMATION 5 34 0.0001822 0.0009566
885 PROTEIN KINASE B SIGNALING 5 34 0.0001822 0.0009566
886 CELLULAR GLUCOSE HOMEOSTASIS 7 75 0.000182 0.0009566
887 SKELETAL MUSCLE CELL DIFFERENTIATION 6 53 0.0001824 0.0009566
888 RESPONSE TO CYTOKINE 25 714 0.0001846 0.0009672
889 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 8 100 0.0001877 0.0009824
890 REGULATION OF ACTIN FILAMENT LENGTH 10 156 0.000193 0.001009
891 THYMIC T CELL SELECTION 4 19 0.0001965 0.00102
892 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 0.0001965 0.00102
893 NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 4 19 0.0001965 0.00102
894 PLATELET MORPHOGENESIS 4 19 0.0001965 0.00102
895 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 4 19 0.0001965 0.00102
896 ATRIOVENTRICULAR VALVE DEVELOPMENT 4 19 0.0001965 0.00102
897 REGULATION OF EXTENT OF CELL GROWTH 8 101 0.0002011 0.001042
898 CAMERA TYPE EYE MORPHOGENESIS 8 101 0.0002011 0.001042
899 VENTRICULAR SEPTUM DEVELOPMENT 6 54 0.0002025 0.001048
900 NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 5 35 0.0002099 0.001084
901 BONE REMODELING 5 35 0.0002099 0.001084
902 CALCIUM ION TRANSMEMBRANE TRANSPORT 10 159 0.0002253 0.001162
903 LYMPHOCYTE COSTIMULATION 7 78 0.0002327 0.001199
904 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 9 131 0.0002399 0.001234
905 OLFACTORY LOBE DEVELOPMENT 5 36 0.0002406 0.001234
906 POSITIVE CHEMOTAXIS 5 36 0.0002406 0.001234
907 HEAD MORPHOGENESIS 5 36 0.0002406 0.001234
908 POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 4 20 0.0002426 0.001239
909 MELANOCYTE DIFFERENTIATION 4 20 0.0002426 0.001239
910 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 4 20 0.0002426 0.001239
911 REGULATION OF MONOCYTE CHEMOTAXIS 4 20 0.0002426 0.001239
912 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 16 365 0.0002472 0.001261
913 REGULATION OF DENDRITIC SPINE DEVELOPMENT 6 56 0.0002479 0.001263
914 PROTEIN AUTOPHOSPHORYLATION 11 192 0.00025 0.001272
915 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 7 79 0.0002519 0.00128
916 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 7 79 0.0002519 0.00128
917 NEGATIVE REGULATION OF PROTEOLYSIS 15 329 0.0002532 0.001285
918 POSITIVE REGULATION OF CELL DIVISION 9 132 0.0002539 0.001287
919 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 11 193 0.0002614 0.001324
920 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 6 57 0.0002734 0.001383
921 CORONARY VASCULATURE DEVELOPMENT 5 37 0.0002746 0.001384
922 MYOBLAST DIFFERENTIATION 5 37 0.0002746 0.001384
923 GLIAL CELL MIGRATION 5 37 0.0002746 0.001384
924 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 9 134 0.0002841 0.00143
925 POSITIVE REGULATION OF CYTOKINE PRODUCTION 16 370 0.0002877 0.001447
926 GLYCEROPHOSPHOLIPID METABOLIC PROCESS 14 297 0.000289 0.001452
927 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 12 228 0.0002895 0.001453
928 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 7 81 0.0002942 0.001475
929 DENDRITIC CELL MIGRATION 4 21 0.0002959 0.001477
930 REGULATION OF RUFFLE ASSEMBLY 4 21 0.0002959 0.001477
931 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 4 21 0.0002959 0.001477
932 RUFFLE ORGANIZATION 4 21 0.0002959 0.001477
933 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 6 58 0.000301 0.001501
934 POSITIVE REGULATION OF ORGAN GROWTH 5 38 0.0003122 0.001555
935 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 9 136 0.0003171 0.001578
936 NEGATIVE REGULATION OF PROTEIN SECRETION 8 108 0.0003185 0.001583
937 PROTEIN MATURATION 13 265 0.0003235 0.001606
938 REGULATION OF TRANSPORTER ACTIVITY 11 198 0.0003255 0.001615
939 RECEPTOR MEDIATED ENDOCYTOSIS 12 231 0.000326 0.001616
940 RESPONSE TO ALKALOID 9 137 0.0003348 0.001657
941 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 5 39 0.0003535 0.001746
942 ASTROCYTE DIFFERENTIATION 5 39 0.0003535 0.001746
943 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 11 200 0.0003546 0.00175
944 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 4 22 0.0003572 0.001751
945 ENDOCARDIAL CUSHION MORPHOGENESIS 4 22 0.0003572 0.001751
946 POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION 4 22 0.0003572 0.001751
947 PROTEIN LOCALIZATION TO CELL SURFACE 4 22 0.0003572 0.001751
948 REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 4 22 0.0003572 0.001751
949 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 4 22 0.0003572 0.001751
950 REGULATION OF MONOOXYGENASE ACTIVITY 6 60 0.0003626 0.001772
951 OLIGODENDROCYTE DIFFERENTIATION 6 60 0.0003626 0.001772
952 LEUKOCYTE HOMEOSTASIS 6 60 0.0003626 0.001772
953 REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 7 84 0.0003681 0.001794
954 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 7 84 0.0003681 0.001794
955 FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 7 84 0.0003681 0.001794
956 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 8 111 0.0003835 0.001867
957 GLUCOSE HOMEOSTASIS 10 170 0.0003851 0.001871
958 CARBOHYDRATE HOMEOSTASIS 10 170 0.0003851 0.001871
959 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 7 85 0.0003958 0.00192
960 POSITIVE REGULATION OF STEM CELL PROLIFERATION 6 61 0.0003969 0.001924
961 NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 5 40 0.0003988 0.001929
962 ENDODERMAL CELL DIFFERENTIATION 5 40 0.0003988 0.001929
963 TISSUE HOMEOSTASIS 10 171 0.0004035 0.001949
964 RESPONSE TO AMINO ACID 8 112 0.0004074 0.001967
965 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 7 86 0.0004251 0.00205
966 RESPONSE TO MAGNESIUM ION 4 23 0.0004271 0.002051
967 REGULATION OF OSTEOBLAST PROLIFERATION 4 23 0.0004271 0.002051
968 STRIATED MUSCLE ADAPTATION 4 23 0.0004271 0.002051
969 NEUROTROPHIN SIGNALING PATHWAY 4 23 0.0004271 0.002051
970 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 8 113 0.0004326 0.002075
971 REGULATION OF TISSUE REMODELING 6 62 0.0004336 0.002078
972 MULTI ORGANISM REPRODUCTIVE PROCESS 28 891 0.0004464 0.002137
973 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 5 41 0.0004484 0.002138
974 REGULATION OF MEMBRANE DEPOLARIZATION 5 41 0.0004484 0.002138
975 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 5 41 0.0004484 0.002138
976 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 5 41 0.0004484 0.002138
977 REGULATION OF EMBRYONIC DEVELOPMENT 8 114 0.000459 0.002186
978 NEUROEPITHELIAL CELL DIFFERENTIATION 6 63 0.000473 0.00225
979 NEGATIVE REGULATION OF DEFENSE RESPONSE 9 144 0.0004827 0.002294
980 RESPONSE TO INTERLEUKIN 1 8 115 0.0004866 0.00231
981 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 7 88 0.000489 0.002319
982 REGULATION OF HISTONE DEACETYLATION 4 24 0.0005061 0.002374
983 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 5 42 0.0005025 0.002374
984 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 4 24 0.0005061 0.002374
985 POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 4 24 0.0005061 0.002374
986 AXON REGENERATION 4 24 0.0005061 0.002374
987 DETECTION OF MECHANICAL STIMULUS 5 42 0.0005025 0.002374
988 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 4 24 0.0005061 0.002374
989 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 5 42 0.0005025 0.002374
990 REGULATION OF ODONTOGENESIS 4 24 0.0005061 0.002374
991 REGULATION OF ANOIKIS 4 24 0.0005061 0.002374
992 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 4 24 0.0005061 0.002374
993 RESPONSE TO IONIZING RADIATION 9 145 0.0005076 0.002379
994 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 6 64 0.0005151 0.002408
995 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 15 352 0.0005155 0.002408
996 REGULATION OF NEUROTRANSMITTER TRANSPORT 6 64 0.0005151 0.002408
997 RESPONSE TO HEAT 7 89 0.0005237 0.002442
998 B CELL DIFFERENTIATION 7 89 0.0005237 0.002442
999 CELLULAR RESPONSE TO INSULIN STIMULUS 9 146 0.0005336 0.002485
1000 LIPID MODIFICATION 11 210 0.0005352 0.00249
1001 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 11 211 0.0005568 0.002588
1002 REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 5 43 0.0005613 0.002607
1003 GLYCEROLIPID METABOLIC PROCESS 15 356 0.0005793 0.002688
1004 BONE TRABECULA MORPHOGENESIS 3 11 0.0005868 0.002701
1005 POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 3 11 0.0005868 0.002701
1006 POSITIVE REGULATION OF FIBROBLAST MIGRATION 3 11 0.0005868 0.002701
1007 POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 3 11 0.0005868 0.002701
1008 EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 3 11 0.0005868 0.002701
1009 LYMPHOID PROGENITOR CELL DIFFERENTIATION 3 11 0.0005868 0.002701
1010 IMMUNOLOGICAL SYNAPSE FORMATION 3 11 0.0005868 0.002701
1011 CORPUS CALLOSUM DEVELOPMENT 3 11 0.0005868 0.002701
1012 POSITIVE REGULATION OF CATABOLIC PROCESS 16 395 0.0005877 0.002702
1013 POSITIVE REGULATION OF COAGULATION 4 25 0.0005951 0.002733
1014 DORSAL VENTRAL PATTERN FORMATION 7 91 0.0005989 0.002748
1015 SOMATIC STEM CELL POPULATION MAINTENANCE 6 66 0.000608 0.002782
1016 REGULATION OF CARDIAC MUSCLE CONTRACTION 6 66 0.000608 0.002782
1017 LENS DEVELOPMENT IN CAMERA TYPE EYE 6 66 0.000608 0.002782
1018 POSITIVE REGULATION OF NEURON DEATH 6 67 0.000659 0.003003
1019 CELL AGING 6 67 0.000659 0.003003
1020 CELLULAR RESPONSE TO DRUG 6 67 0.000659 0.003003
1021 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 6 67 0.000659 0.003003
1022 PROTEIN LOCALIZATION TO CELL PERIPHERY 9 151 0.0006805 0.003098
1023 ACTIN FILAMENT BASED MOVEMENT 7 93 0.0006825 0.003101
1024 MULTICELLULAR ORGANISM METABOLIC PROCESS 7 93 0.0006825 0.003101
1025 POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 4 26 0.0006946 0.003138
1026 LUNG MORPHOGENESIS 5 45 0.0006944 0.003138
1027 NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 4 26 0.0006946 0.003138
1028 MESODERMAL CELL DIFFERENTIATION 4 26 0.0006946 0.003138
1029 SMOOTH MUSCLE CONTRACTION 5 45 0.0006944 0.003138
1030 REGULATION OF CELL FATE COMMITMENT 4 26 0.0006946 0.003138
1031 MEMBRANE DOCKING 6 68 0.0007134 0.003213
1032 REGULATION OF PHAGOCYTOSIS 6 68 0.0007134 0.003213
1033 AMINOGLYCAN CATABOLIC PROCESS 6 68 0.0007134 0.003213
1034 PHOSPHOLIPID METABOLIC PROCESS 15 364 0.0007273 0.003273
1035 POSITIVE REGULATION OF MITOTIC CELL CYCLE 8 123 0.0007602 0.003414
1036 MULTICELLULAR ORGANISMAL SIGNALING 8 123 0.0007602 0.003414
1037 CARDIAC LEFT VENTRICLE MORPHOGENESIS 3 12 0.0007732 0.003423
1038 ROUNDABOUT SIGNALING PATHWAY 3 12 0.0007732 0.003423
1039 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH 3 12 0.0007732 0.003423
1040 REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 3 12 0.0007732 0.003423
1041 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 6 69 0.0007711 0.003423
1042 POLARIZED EPITHELIAL CELL DIFFERENTIATION 3 12 0.0007732 0.003423
1043 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 5 46 0.0007691 0.003423
1044 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 3 12 0.0007732 0.003423
1045 NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY 3 12 0.0007732 0.003423
1046 POSITIVE REGULATION OF PHAGOCYTOSIS 5 46 0.0007691 0.003423
1047 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 3 12 0.0007732 0.003423
1048 REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 12 0.0007732 0.003423
1049 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 6 69 0.0007711 0.003423
1050 RENAL FILTRATION 3 12 0.0007732 0.003423
1051 NEGATIVE REGULATION OF HEART GROWTH 3 12 0.0007732 0.003423
1052 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 7 95 0.000775 0.003428
1053 POSITIVE REGULATION OF HEART GROWTH 4 27 0.0008053 0.003542
1054 CELL PROLIFERATION IN FOREBRAIN 4 27 0.0008053 0.003542
1055 POSITIVE REGULATION OF FILOPODIUM ASSEMBLY 4 27 0.0008053 0.003542
1056 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 4 27 0.0008053 0.003542
1057 NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 4 27 0.0008053 0.003542
1058 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 4 27 0.0008053 0.003542
1059 SENSORY PERCEPTION OF MECHANICAL STIMULUS 9 155 0.0008205 0.003605
1060 MAINTENANCE OF LOCATION IN CELL 7 96 0.0008249 0.003621
1061 THYMUS DEVELOPMENT 5 47 0.0008496 0.003723
1062 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 5 47 0.0008496 0.003723
1063 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 6 71 0.0008973 0.003928
1064 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 4 28 0.000928 0.004047
1065 REGULATION OF NEUROBLAST PROLIFERATION 4 28 0.000928 0.004047
1066 MUSCLE HYPERTROPHY 4 28 0.000928 0.004047
1067 MAMMARY GLAND DUCT MORPHOGENESIS 4 28 0.000928 0.004047
1068 MEMORY 7 98 0.0009322 0.004061
1069 RESPONSE TO AXON INJURY 5 48 0.0009363 0.004076
1070 NEGATIVE REGULATION OF CELL ACTIVATION 9 158 0.0009401 0.004088
1071 CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 3 13 0.0009935 0.004276
1072 SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL INTERNEURON MIGRATION 3 13 0.0009935 0.004276
1073 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 3 13 0.0009935 0.004276
1074 SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION 3 13 0.0009935 0.004276
1075 HEMATOPOIETIC STEM CELL PROLIFERATION 3 13 0.0009935 0.004276
1076 HEART VALVE FORMATION 3 13 0.0009935 0.004276
1077 NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 3 13 0.0009935 0.004276
1078 RESPONSE TO PARATHYROID HORMONE 3 13 0.0009935 0.004276
1079 NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 3 13 0.0009935 0.004276
1080 EXTRACELLULAR FIBRIL ORGANIZATION 3 13 0.0009935 0.004276
1081 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 3 13 0.0009935 0.004276
1082 POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 12 263 0.001026 0.004414
1083 NEGATIVE REGULATION OF PEPTIDE SECRETION 5 49 0.001029 0.004415
1084 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 5 49 0.001029 0.004415
1085 CARDIAC SEPTUM MORPHOGENESIS 5 49 0.001029 0.004415
1086 POSITIVE REGULATION OF PROTEIN BINDING 6 73 0.001039 0.004447
1087 HIPPOCAMPUS DEVELOPMENT 6 73 0.001039 0.004447
1088 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 7 100 0.00105 0.004491
1089 CELL PROJECTION ASSEMBLY 12 264 0.00106 0.004518
1090 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 4 29 0.001063 0.004518
1091 REGULATION OF VACUOLAR TRANSPORT 4 29 0.001063 0.004518
1092 STEM CELL DIVISION 4 29 0.001063 0.004518
1093 RESPONSE TO ISCHEMIA 4 29 0.001063 0.004518
1094 MUSCLE ADAPTATION 4 29 0.001063 0.004518
1095 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 4 29 0.001063 0.004518
1096 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 6 74 0.001116 0.004737
1097 LYMPHOCYTE HOMEOSTASIS 5 50 0.001129 0.004781
1098 REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 50 0.001129 0.004781
1099 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 5 50 0.001129 0.004781
1100 LEARNING 8 131 0.001146 0.004843
1101 NEGATIVE REGULATION OF BINDING 8 131 0.001146 0.004843
1102 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 7 102 0.00118 0.004981
1103 GRANULOCYTE MIGRATION 6 75 0.001197 0.005049
1104 B CELL ACTIVATION 8 132 0.001203 0.005072
1105 ESTABLISHMENT OR MAINTENANCE OF EPITHELIAL CELL APICAL BASAL POLARITY 4 30 0.001212 0.005088
1106 CEREBELLAR CORTEX MORPHOGENESIS 4 30 0.001212 0.005088
1107 MYOTUBE CELL DEVELOPMENT 4 30 0.001212 0.005088
1108 REGULATION OF VASCULAR PERMEABILITY 4 30 0.001212 0.005088
1109 HORMONE METABOLIC PROCESS 9 164 0.001222 0.005127
1110 REGULATION OF NEUROTRANSMITTER SECRETION 5 51 0.001236 0.005172
1111 NEURAL CREST CELL MIGRATION 5 51 0.001236 0.005172
1112 REGULATION OF INTERLEUKIN 12 PRODUCTION 5 51 0.001236 0.005172
1113 STRESS FIBER ASSEMBLY 3 14 0.00125 0.005183
1114 CONTRACTILE ACTIN FILAMENT BUNDLE ASSEMBLY 3 14 0.00125 0.005183
1115 POSITIVE REGULATION OF VACUOLAR TRANSPORT 3 14 0.00125 0.005183
1116 POSITIVE REGULATION OF HISTONE DEACETYLATION 3 14 0.00125 0.005183
1117 EPITHELIAL CELL CELL ADHESION 3 14 0.00125 0.005183
1118 ATRIAL SEPTUM MORPHOGENESIS 3 14 0.00125 0.005183
1119 CONVERGENT EXTENSION 3 14 0.00125 0.005183
1120 CATECHOLAMINE TRANSPORT 3 14 0.00125 0.005183
1121 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 3 14 0.00125 0.005183
1122 RESPONSE TO LAMINAR FLUID SHEAR STRESS 3 14 0.00125 0.005183
1123 REGULATION OF CALCIUM MEDIATED SIGNALING 6 76 0.001283 0.005314
1124 AMINOGLYCAN METABOLIC PROCESS 9 166 0.00133 0.005504
1125 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 5 52 0.00135 0.005584
1126 REGULATION OF CELL DIVISION 12 272 0.001368 0.005653
1127 REGULATION OF MICROTUBULE POLYMERIZATION 4 31 0.001374 0.005663
1128 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 4 31 0.001374 0.005663
1129 REGULATION OF PLATELET ACTIVATION 4 31 0.001374 0.005663
1130 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 8 135 0.00139 0.005724
1131 REGULATION OF MULTI ORGANISM PROCESS 17 470 0.001392 0.005728
1132 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 5 53 0.001472 0.006038
1133 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 5 53 0.001472 0.006038
1134 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 5 53 0.001472 0.006038
1135 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 14 351 0.001475 0.006046
1136 PLASMA MEMBRANE ORGANIZATION 10 203 0.001507 0.006167
1137 NEGATIVE REGULATION OF CATABOLIC PROCESS 10 203 0.001507 0.006167
1138 NEGATIVE REGULATION OF HISTONE ACETYLATION 3 15 0.001544 0.00628
1139 REGULATION OF MESODERM DEVELOPMENT 3 15 0.001544 0.00628
1140 GRANULOCYTE DIFFERENTIATION 3 15 0.001544 0.00628
1141 REGULATION OF NEUROTRANSMITTER UPTAKE 3 15 0.001544 0.00628
1142 CHRONIC INFLAMMATORY RESPONSE 3 15 0.001544 0.00628
1143 VENOUS BLOOD VESSEL DEVELOPMENT 3 15 0.001544 0.00628
1144 MRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 3 15 0.001544 0.00628
1145 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 4 32 0.001551 0.006292
1146 REGULATION OF ACTIN CYTOSKELETON REORGANIZATION 4 32 0.001551 0.006292
1147 PEPTIDE HORMONE PROCESSING 4 32 0.001551 0.006292
1148 AMINOGLYCAN BIOSYNTHETIC PROCESS 7 107 0.001558 0.006315
1149 REGULATION OF STRIATED MUSCLE CONTRACTION 6 79 0.001568 0.006349
1150 NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 5 54 0.001601 0.006467
1151 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 5 54 0.001601 0.006467
1152 PLACENTA DEVELOPMENT 8 138 0.001599 0.006467
1153 RESPONSE TO INSULIN 10 205 0.001621 0.00654
1154 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 9 172 0.0017 0.006854
1155 NEURON RECOGNITION 4 33 0.001743 0.006974
1156 PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 4 33 0.001743 0.006974
1157 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 55 0.001739 0.006974
1158 POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 4 33 0.001743 0.006974
1159 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 4 33 0.001743 0.006974
1160 NEURON PROJECTION REGENERATION 4 33 0.001743 0.006974
1161 NEGATIVE REGULATION OF JNK CASCADE 4 33 0.001743 0.006974
1162 RESPONSE TO DEXAMETHASONE 4 33 0.001743 0.006974
1163 RESPONSE TO HYDROGEN PEROXIDE 7 109 0.001734 0.006974
1164 NON CANONICAL WNT SIGNALING PATHWAY 8 140 0.001751 0.007001
1165 REGULATION OF FIBROBLAST PROLIFERATION 6 81 0.001783 0.007116
1166 REGULATION OF JUN KINASE ACTIVITY 6 81 0.001783 0.007116
1167 REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 7 110 0.001827 0.007284
1168 ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY 3 16 0.001878 0.007375
1169 REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 3 16 0.001878 0.007375
1170 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 3 16 0.001878 0.007375
1171 MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION 3 16 0.001878 0.007375
1172 CARDIAC MYOFIBRIL ASSEMBLY 3 16 0.001878 0.007375
1173 REGULATION OF MONONUCLEAR CELL MIGRATION 3 16 0.001878 0.007375
1174 REGULATION OF MACROPHAGE CHEMOTAXIS 3 16 0.001878 0.007375
1175 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 3 16 0.001878 0.007375
1176 POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 3 16 0.001878 0.007375
1177 REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 3 16 0.001878 0.007375
1178 CARDIAC RIGHT VENTRICLE MORPHOGENESIS 3 16 0.001878 0.007375
1179 MEGAKARYOCYTE DEVELOPMENT 3 16 0.001878 0.007375
1180 POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 3 16 0.001878 0.007375
1181 PARAXIAL MESODERM DEVELOPMENT 3 16 0.001878 0.007375
1182 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 3 16 0.001878 0.007375
1183 POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE 3 16 0.001878 0.007375
1184 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 3 16 0.001878 0.007375
1185 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 3 16 0.001878 0.007375
1186 SMAD PROTEIN SIGNAL TRANSDUCTION 5 56 0.001885 0.007389
1187 PEPTIDE CROSS LINKING 5 56 0.001885 0.007389
1188 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 34 0.001951 0.007604
1189 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 4 34 0.001951 0.007604
1190 REGULATION OF PROTEIN DEACETYLATION 4 34 0.001951 0.007604
1191 PROTEIN DESTABILIZATION 4 34 0.001951 0.007604
1192 OLIGODENDROCYTE DEVELOPMENT 4 34 0.001951 0.007604
1193 NEURAL TUBE PATTERNING 4 34 0.001951 0.007604
1194 BRAIN MORPHOGENESIS 4 34 0.001951 0.007604
1195 POSITIVE REGULATION OF PROTEIN SECRETION 10 211 0.002004 0.007798
1196 SKIN DEVELOPMENT 10 211 0.002004 0.007798
1197 ORGAN REGENERATION 6 83 0.00202 0.007846
1198 REGULATION OF POTASSIUM ION TRANSPORT 6 83 0.00202 0.007846
1199 ANATOMICAL STRUCTURE HOMEOSTASIS 12 285 0.002023 0.007849
1200 ZYMOGEN ACTIVATION 7 112 0.002025 0.007852
1201 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 5 57 0.00204 0.007897
1202 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 5 57 0.00204 0.007897
1203 REGULATION OF AUTOPHAGY 11 249 0.00212 0.008198
1204 NEGATIVE REGULATION OF WOUND HEALING 5 58 0.002204 0.008518
1205 REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 3 17 0.002254 0.008639
1206 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 3 17 0.002254 0.008639
1207 NEGATIVE REGULATION OF STEM CELL PROLIFERATION 3 17 0.002254 0.008639
1208 POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 3 17 0.002254 0.008639
1209 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 7 114 0.00224 0.008639
1210 DORSAL VENTRAL NEURAL TUBE PATTERNING 3 17 0.002254 0.008639
1211 MAMMARY GLAND ALVEOLUS DEVELOPMENT 3 17 0.002254 0.008639
1212 MAMMARY GLAND LOBULE DEVELOPMENT 3 17 0.002254 0.008639
1213 NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 3 17 0.002254 0.008639
1214 DEFINITIVE HEMOPOIESIS 3 17 0.002254 0.008639
1215 SINGLE ORGANISM CELLULAR LOCALIZATION 26 898 0.002264 0.008669
1216 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 6 85 0.00228 0.008704
1217 PALATE DEVELOPMENT 6 85 0.00228 0.008704
1218 EPHRIN RECEPTOR SIGNALING PATHWAY 6 85 0.00228 0.008704
1219 POSITIVE REGULATION OF CHROMATIN MODIFICATION 6 85 0.00228 0.008704
1220 RESPONSE TO CALCIUM ION 7 115 0.002353 0.008975
1221 REGULATION OF T CELL PROLIFERATION 8 147 0.002378 0.009054
1222 REGULATION OF GLIAL CELL DIFFERENTIATION 5 59 0.002378 0.009054
1223 REGULATION OF CELL CYCLE 27 949 0.00239 0.009094
1224 POSITIVE REGULATION OF SECRETION 14 370 0.002397 0.009113
1225 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 36 0.002418 0.00916
1226 T CELL PROLIFERATION 4 36 0.002418 0.00916
1227 NEGATIVE REGULATION OF HISTONE MODIFICATION 4 36 0.002418 0.00916
1228 POSITIVE REGULATION OF PROTEIN ACETYLATION 4 36 0.002418 0.00916
1229 POSITIVE REGULATION OF B CELL ACTIVATION 6 86 0.002419 0.00916
1230 RESPONSE TO TEMPERATURE STIMULUS 8 148 0.00248 0.009382
1231 RESPONSE TO RADIATION 15 413 0.002516 0.009511
1232 REGULATION OF GLUCOSE IMPORT 5 60 0.002561 0.009663
1233 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 5 60 0.002561 0.009663
1234 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 6 87 0.002565 0.009671
1235 REGULATION OF CYTOKINE SECRETION 8 149 0.002586 0.009742
1236 REGULATION OF RECEPTOR ACTIVITY 7 117 0.002594 0.009756
1237 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 7 117 0.002594 0.009756
1238 REGULATION OF MITOCHONDRIAL DEPOLARIZATION 3 18 0.002673 0.009935
1239 POSITIVE REGULATION OF B CELL PROLIFERATION 4 37 0.002678 0.009935
1240 LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT 3 18 0.002673 0.009935
1241 CATECHOLAMINE BIOSYNTHETIC PROCESS 3 18 0.002673 0.009935
1242 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 3 18 0.002673 0.009935
1243 RESPONSE TO CAFFEINE 3 18 0.002673 0.009935
1244 CARDIAC MUSCLE CELL ACTION POTENTIAL 4 37 0.002678 0.009935
1245 KIDNEY MESENCHYME DEVELOPMENT 3 18 0.002673 0.009935
1246 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 4 37 0.002678 0.009935
1247 POSITIVE REGULATION OF PROTEIN DEACETYLATION 3 18 0.002673 0.009935
1248 ESTABLISHMENT OR MAINTENANCE OF APICAL BASAL CELL POLARITY 4 37 0.002678 0.009935
1249 OSTEOBLAST DEVELOPMENT 3 18 0.002673 0.009935
1250 ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 4 37 0.002678 0.009935
1251 NEPHRON TUBULE FORMATION 3 18 0.002673 0.009935
1252 MUSCLE CELL MIGRATION 3 18 0.002673 0.009935
1253 UTERUS DEVELOPMENT 3 18 0.002673 0.009935
1254 CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 3 18 0.002673 0.009935
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 82 1476 1.674e-24 1.555e-21
2 MACROMOLECULAR COMPLEX BINDING 78 1399 2.438e-23 1.132e-20
3 CELL ADHESION MOLECULE BINDING 31 186 7.202e-23 2.23e-20
4 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 49 629 1.592e-20 3.698e-18
5 INTEGRIN BINDING 23 105 4.552e-20 8.458e-18
6 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 32 315 5.819e-17 9.01e-15
7 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 62 1199 7.348e-17 9.752e-15
8 GLYCOSAMINOGLYCAN BINDING 26 205 2.493e-16 2.895e-14
9 PROTEIN COMPLEX BINDING 53 935 4.279e-16 4.416e-14
10 HEPARIN BINDING 23 157 5.632e-16 5.232e-14
11 GROWTH FACTOR BINDING 20 123 5.985e-15 5.055e-13
12 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 25 226 2.39e-14 1.851e-12
13 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 29 328 6.748e-14 4.822e-12
14 SEQUENCE SPECIFIC DNA BINDING 52 1037 1.156e-13 7.673e-12
15 SULFUR COMPOUND BINDING 24 234 4.273e-13 2.647e-11
16 REGULATORY REGION NUCLEIC ACID BINDING 43 818 4.341e-12 2.521e-10
17 DOUBLE STRANDED DNA BINDING 41 764 7.548e-12 4.125e-10
18 TRANSCRIPTION FACTOR BINDING 33 524 1.543e-11 7.963e-10
19 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 14 81 3.192e-11 1.561e-09
20 IDENTICAL PROTEIN BINDING 52 1209 3.865e-11 1.795e-09
21 GLYCOPROTEIN BINDING 15 101 6.001e-11 2.655e-09
22 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 12 64 3.097e-10 1.251e-08
23 ENZYME BINDING 63 1737 3.08e-10 1.251e-08
24 PROTEIN TYROSINE KINASE ACTIVITY 18 176 4.077e-10 1.578e-08
25 PROTEIN KINASE ACTIVITY 34 640 6.981e-10 2.594e-08
26 PROTEIN DOMAIN SPECIFIC BINDING 33 624 1.418e-09 5.068e-08
27 MOLECULAR FUNCTION REGULATOR 51 1353 5.84e-09 2.01e-07
28 CHROMATIN BINDING 26 435 7.294e-09 2.42e-07
29 PROTEIN DIMERIZATION ACTIVITY 45 1149 1.689e-08 5.412e-07
30 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 12 90 1.79e-08 5.544e-07
31 KINASE ACTIVITY 37 842 1.989e-08 5.961e-07
32 CYTOSKELETAL PROTEIN BINDING 36 819 3.12e-08 9.057e-07
33 METALLOENDOPEPTIDASE INHIBITOR ACTIVITY 6 14 4.005e-08 1.128e-06
34 HISTONE DEACETYLASE BINDING 12 105 1.033e-07 2.822e-06
35 CORE PROMOTER PROXIMAL REGION DNA BINDING 22 371 1.245e-07 3.306e-06
36 ACTIN BINDING 22 393 3.352e-07 8.651e-06
37 CALCIUM ION BINDING 30 697 7.35e-07 1.845e-05
38 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 11 104 7.781e-07 1.902e-05
39 COLLAGEN BINDING 9 65 8.053e-07 1.918e-05
40 BETA CATENIN BINDING 10 84 8.262e-07 1.919e-05
41 G PROTEIN COUPLED RECEPTOR BINDING 17 259 8.642e-07 1.958e-05
42 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 37 992 1.164e-06 2.574e-05
43 ION CHANNEL BINDING 11 111 1.497e-06 3.228e-05
44 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 9 70 1.529e-06 3.228e-05
45 PEPTIDASE REGULATOR ACTIVITY 15 214 1.699e-06 3.359e-05
46 GROWTH FACTOR ACTIVITY 13 160 1.639e-06 3.359e-05
47 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC 5 14 1.699e-06 3.359e-05
48 CYTOKINE BINDING 10 92 1.93e-06 3.736e-05
49 LIPID BINDING 28 657 2.12e-06 4.02e-05
50 SIGNAL TRANSDUCER ACTIVITY 53 1731 2.239e-06 4.16e-05
51 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 17 303 7.213e-06 0.0001314
52 WNT PROTEIN BINDING 6 31 7.83e-06 0.0001386
53 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 25 588 7.909e-06 0.0001386
54 PROTEIN HOMODIMERIZATION ACTIVITY 28 722 1.243e-05 0.0002139
55 EXTRACELLULAR MATRIX BINDING 7 51 1.467e-05 0.0002478
56 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 14 228 1.713e-05 0.0002841
57 WNT ACTIVATED RECEPTOR ACTIVITY 5 22 2.014e-05 0.0003283
58 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 8 76 2.638e-05 0.0004225
59 STRUCTURAL CONSTITUENT OF CYTOSKELETON 9 100 2.956e-05 0.0004654
60 INSULIN LIKE GROWTH FACTOR BINDING 5 25 3.909e-05 0.0005996
61 GROWTH FACTOR RECEPTOR BINDING 10 129 3.937e-05 0.0005996
62 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 6 43 5.528e-05 0.0008283
63 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 7 65 7.304e-05 0.001077
64 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 11 168 7.699e-05 0.001118
65 TRANSFORMING GROWTH FACTOR BETA BINDING 4 16 9.578e-05 0.001348
66 SH3 DOMAIN BINDING 9 116 9.504e-05 0.001348
67 KINASE BINDING 23 606 0.0001043 0.001447
68 ENHANCER BINDING 8 93 0.000113 0.001521
69 RECEPTOR ACTIVITY 46 1649 0.0001123 0.001521
70 ENZYME INHIBITOR ACTIVITY 17 378 0.0001172 0.001556
71 PEPTIDASE INHIBITOR ACTIVITY 11 177 0.0001227 0.001606
72 PROTEIN KINASE C BINDING 6 50 0.0001313 0.001695
73 ENZYME REGULATOR ACTIVITY 31 959 0.000134 0.001705
74 SMAD BINDING 7 72 0.0001407 0.001766
75 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 6 51 0.0001469 0.00182
76 PROTEIN HETERODIMERIZATION ACTIVITY 19 468 0.0001789 0.002187
77 E BOX BINDING 5 34 0.0001822 0.002199
78 ATPASE BINDING 7 76 0.0001978 0.002356
79 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 8 101 0.0002011 0.002365
80 GLYCOLIPID BINDING 4 20 0.0002426 0.002782
81 FRIZZLED BINDING 5 36 0.0002406 0.002782
82 PROTEASE BINDING 8 104 0.000246 0.002787
83 STRUCTURAL MOLECULE ACTIVITY 25 732 0.000269 0.00301
84 ACTIVATING TRANSCRIPTION FACTOR BINDING 6 57 0.0002734 0.003024
85 MYOSIN BINDING 6 59 0.0003306 0.003614
86 STEROID BINDING 7 91 0.0005989 0.00647
87 PROTEIN PHOSPHATASE BINDING 8 120 0.000646 0.006898
88 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 4 26 0.0006946 0.007333
89 SIGNALING RECEPTOR ACTIVITY 38 1393 0.0007101 0.007412
90 TAU PROTEIN BINDING 3 12 0.0007732 0.007981
91 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 4 28 0.000928 0.00927
92 FIBRONECTIN BINDING 4 28 0.000928 0.00927
93 HISTONE ACETYLTRANSFERASE BINDING 4 28 0.000928 0.00927
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 53 426 4.831e-32 2.821e-29
2 CELL SURFACE 60 757 1.696e-25 4.952e-23
3 CELL PROJECTION 91 1786 1.128e-24 2.195e-22
4 PROTEINACEOUS EXTRACELLULAR MATRIX 42 356 1.549e-24 2.261e-22
5 CELL JUNCTION 70 1151 5.41e-23 6.319e-21
6 CELL SUBSTRATE JUNCTION 41 398 1.031e-21 1.004e-19
7 EXTRACELLULAR SPACE 74 1376 3.595e-21 2.999e-19
8 ANCHORING JUNCTION 44 489 6.586e-21 4.808e-19
9 CELL LEADING EDGE 35 350 3.055e-18 1.982e-16
10 MEMBRANE REGION 58 1134 1.431e-15 8.36e-14
11 CELL CELL JUNCTION 33 383 2.438e-15 1.294e-13
12 EXTRACELLULAR MATRIX COMPONENT 20 125 8.257e-15 4.018e-13
13 ACTIN CYTOSKELETON 34 444 2.925e-14 1.314e-12
14 NEURON PART 58 1265 1.622e-13 6.768e-12
15 PLASMA MEMBRANE REGION 48 929 3.933e-13 1.531e-11
16 CELL PROJECTION PART 47 946 2.861e-12 1.044e-10
17 EXTERNAL SIDE OF PLASMA MEMBRANE 23 238 4.628e-12 1.59e-10
18 NEURON PROJECTION 46 942 9.081e-12 2.946e-10
19 CELL BODY 32 494 1.539e-11 4.73e-10
20 BASEMENT MEMBRANE 15 93 1.765e-11 5.154e-10
21 LAMELLIPODIUM 19 172 3.425e-11 9.524e-10
22 SIDE OF MEMBRANE 29 428 5.003e-11 1.328e-09
23 SOMATODENDRITIC COMPARTMENT 36 650 6.679e-11 1.696e-09
24 ACTIN FILAMENT BUNDLE 12 57 7.362e-11 1.792e-09
25 PLATELET ALPHA GRANULE 13 75 1.573e-10 3.674e-09
26 ACTOMYOSIN 12 62 2.095e-10 4.707e-09
27 INTRINSIC COMPONENT OF PLASMA MEMBRANE 61 1649 2.89e-10 6.028e-09
28 SYNAPSE 38 754 2.885e-10 6.028e-09
29 MEMBRANE MICRODOMAIN 22 288 1.281e-09 2.579e-08
30 INTRACELLULAR VESICLE 50 1259 1.504e-09 2.927e-08
31 CONTRACTILE FIBER 17 211 4.626e-08 8.714e-07
32 CELL PROJECTION MEMBRANE 20 298 6.419e-08 1.172e-06
33 SECRETORY GRANULE LUMEN 11 85 9.713e-08 1.719e-06
34 CYTOPLASMIC VESICLE PART 29 601 1.077e-07 1.851e-06
35 VESICLE LUMEN 12 106 1.148e-07 1.916e-06
36 APICAL JUNCTION COMPLEX 13 128 1.243e-07 2.017e-06
37 SYNAPSE PART 29 610 1.474e-07 2.327e-06
38 PLATELET ALPHA GRANULE LUMEN 9 55 1.84e-07 2.827e-06
39 SECRETORY GRANULE 21 352 2.193e-07 3.254e-06
40 APICAL PLASMA MEMBRANE 19 292 2.229e-07 3.254e-06
41 APICAL PART OF CELL 21 361 3.329e-07 4.742e-06
42 MYELIN SHEATH 14 168 4.788e-07 6.657e-06
43 POSTSYNAPSE 21 378 7.057e-07 9.584e-06
44 RUFFLE 13 156 1.231e-06 1.634e-05
45 SECRETORY VESICLE 23 461 1.334e-06 1.732e-05
46 CELL CELL ADHERENS JUNCTION 8 54 1.966e-06 2.496e-05
47 AXON 21 418 3.487e-06 4.333e-05
48 NUCLEAR CHROMATIN 17 291 4.221e-06 5.136e-05
49 CELL CORTEX 15 238 6.273e-06 7.477e-05
50 ACTIN BASED CELL PROJECTION 13 181 6.429e-06 7.51e-05
51 LEADING EDGE MEMBRANE 11 134 9.426e-06 0.0001079
52 CYTOSKELETON 56 1967 9.923e-06 0.0001114
53 EXTRINSIC COMPONENT OF MEMBRANE 15 252 1.244e-05 0.0001371
54 CYTOPLASMIC REGION 16 287 1.451e-05 0.000153
55 ACTIN FILAMENT 8 70 1.433e-05 0.000153
56 BASAL PART OF CELL 7 51 1.467e-05 0.000153
57 GOLGI LUMEN 9 94 1.795e-05 0.0001839
58 COMPLEX OF COLLAGEN TRIMERS 5 23 2.541e-05 0.0002558
59 SARCOLEMMA 10 125 3.002e-05 0.0002971
60 CORTICAL ACTIN CYTOSKELETON 7 58 3.467e-05 0.0003374
61 DENDRITE 20 451 3.616e-05 0.0003462
62 AXON PART 13 219 4.852e-05 0.000457
63 T TUBULE 6 45 7.193e-05 0.0006668
64 CHROMATIN 19 441 8.295e-05 0.0007569
65 GOLGI APPARATUS 42 1445 9.446e-05 0.0008487
66 FILOPODIUM 8 94 0.0001218 0.001078
67 BASOLATERAL PLASMA MEMBRANE 12 211 0.0001414 0.001232
68 BASAL PLASMA MEMBRANE 5 33 0.0001575 0.001352
69 MICROVILLUS 7 75 0.000182 0.001541
70 PLASMA MEMBRANE PROTEIN COMPLEX 20 510 0.0001921 0.001602
71 ENDOCYTIC VESICLE 13 256 0.0002317 0.001906
72 RUFFLE MEMBRANE 7 80 0.0002724 0.00221
73 CORTICAL CYTOSKELETON 7 81 0.0002942 0.002354
74 TRANSCRIPTION FACTOR COMPLEX 14 298 0.000299 0.00236
75 EXCITATORY SYNAPSE 11 197 0.0003117 0.002427
76 LYSOSOMAL LUMEN 7 88 0.000489 0.003709
77 COLLAGEN TRIMER 7 88 0.000489 0.003709
78 VESICLE MEMBRANE 19 512 0.0005456 0.004085
79 PERINUCLEAR REGION OF CYTOPLASM 22 642 0.0005977 0.004418
80 CELL CORTEX PART 8 119 0.0006111 0.004461
81 I BAND 8 121 0.0006824 0.00486
82 NEURON SPINE 8 121 0.0006824 0.00486
83 ENDOCYTIC VESICLE MEMBRANE 9 152 0.0007135 0.00502
84 RECEPTOR COMPLEX 14 327 0.000751 0.005221
85 OUTER MEMBRANE 10 190 0.0009152 0.006288
86 PLATELET ALPHA GRANULE MEMBRANE 3 13 0.0009935 0.006746
87 NEURON PROJECTION TERMINUS 8 129 0.001037 0.006964
88 VACUOLE 33 1180 0.001068 0.00709
89 LATERAL PLASMA MEMBRANE 5 50 0.001129 0.00741
90 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 4 30 0.001212 0.007862
91 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 8 136 0.001457 0.009351

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 31 200 6.831e-22 1.209e-19
2 hsa04514_Cell_adhesion_molecules_.CAMs. 22 136 2.851e-16 2.523e-14
3 hsa04810_Regulation_of_actin_cytoskeleton 24 214 5.906e-14 3.485e-12
4 hsa04670_Leukocyte_transendothelial_migration 18 117 3.761e-13 1.664e-11
5 hsa04512_ECM.receptor_interaction 13 85 7.967e-10 2.82e-08
6 hsa04010_MAPK_signaling_pathway 18 268 2.925e-07 8.628e-06
7 hsa04360_Axon_guidance 12 130 1.073e-06 2.713e-05
8 hsa04520_Adherens_junction 9 73 2.189e-06 4.844e-05
9 hsa04666_Fc_gamma_R.mediated_phagocytosis 9 95 1.956e-05 0.0003847
10 hsa04340_Hedgehog_signaling_pathway 7 56 2.747e-05 0.0004862
11 hsa04722_Neurotrophin_signaling_pathway 10 127 3.442e-05 0.0005539
12 hsa04530_Tight_junction 10 133 5.111e-05 0.0007538
13 hsa04350_TGF.beta_signaling_pathway 8 85 5.954e-05 0.0008106
14 hsa04640_Hematopoietic_cell_lineage 8 88 7.633e-05 0.0009651
15 hsa04662_B_cell_receptor_signaling_pathway 7 75 0.000182 0.002148
16 hsa04062_Chemokine_signaling_pathway 11 189 0.0002181 0.002413
17 hsa04310_Wnt_signaling_pathway 9 151 0.0006805 0.007085
18 hsa04380_Osteoclast_differentiation 8 128 0.0009863 0.009699
19 hsa04664_Fc_epsilon_RI_signaling_pathway 6 79 0.001568 0.01455
20 hsa04660_T_cell_receptor_signaling_pathway 7 108 0.001644 0.01455
21 hsa04020_Calcium_signaling_pathway 9 177 0.002068 0.01743
22 hsa04270_Vascular_smooth_muscle_contraction 7 116 0.002471 0.01988
23 hsa04916_Melanogenesis 6 101 0.005361 0.04126
24 hsa04370_VEGF_signaling_pathway 5 76 0.007064 0.0521
25 hsa04012_ErbB_signaling_pathway 5 87 0.01229 0.08367
26 hsa04914_Progesterone.mediated_oocyte_maturation 5 87 0.01229 0.08367
27 hsa04144_Endocytosis 8 203 0.01568 0.1028
28 hsa04650_Natural_killer_cell_mediated_cytotoxicity 6 136 0.02113 0.1333
29 hsa04910_Insulin_signaling_pathway 6 138 0.02251 0.1333
30 hsa04920_Adipocytokine_signaling_pathway 4 68 0.02259 0.1333
31 hsa04730_Long.term_depression 4 70 0.02482 0.1417
32 hsa04614_Renin.angiotensin_system 2 17 0.02895 0.1601
33 hsa04150_mTOR_signaling_pathway 3 52 0.04895 0.2626
34 hsa04210_Apoptosis 4 89 0.05258 0.2737
35 hsa04621_NOD.like_receptor_signaling_pathway 3 59 0.06653 0.3364
36 hsa04620_Toll.like_receptor_signaling_pathway 4 102 0.07838 0.3854
37 hsa03320_PPAR_signaling_pathway 3 70 0.09902 0.4737
38 hsa04145_Phagosome 5 156 0.1018 0.474
39 hsa04130_SNARE_interactions_in_vesicular_transport 2 36 0.1105 0.5014
40 hsa04960_Aldosterone.regulated_sodium_reabsorption 2 42 0.1422 0.6292
41 hsa04962_Vasopressin.regulated_water_reabsorption 2 44 0.1532 0.6455
42 hsa04973_Carbohydrate_digestion_and_absorption 2 44 0.1532 0.6455
43 hsa04970_Salivary_secretion 3 89 0.1665 0.6854
44 hsa04540_Gap_junction 3 90 0.1704 0.6854
45 hsa04672_Intestinal_immune_network_for_IgA_production 2 49 0.1812 0.7127
46 hsa00562_Inositol_phosphate_metabolism 2 57 0.2274 0.8488
47 hsa04630_Jak.STAT_signaling_pathway 4 155 0.2302 0.8488
48 hsa04114_Oocyte_meiosis 3 114 0.2691 0.9721
49 hsa04115_p53_signaling_pathway 2 69 0.2977 1
50 hsa04610_Complement_and_coagulation_cascades 2 69 0.2977 1
51 hsa04142_Lysosome 3 121 0.2992 1
52 hsa04720_Long.term_potentiation 2 70 0.3035 1
53 hsa04110_Cell_cycle 3 128 0.3294 1
54 hsa04070_Phosphatidylinositol_signaling_system 2 78 0.3499 1
55 hsa04974_Protein_digestion_and_absorption 2 81 0.367 1
56 hsa04912_GnRH_signaling_pathway 2 101 0.4757 1
57 hsa04972_Pancreatic_secretion 2 101 0.4757 1
58 hsa04141_Protein_processing_in_endoplasmic_reticulum 2 168 0.7467 1

Quest ID: a409e464d83afe577613ad2adf48c757